{"title":"Drug Development \u0026 Bioanalysis","description":null,"products":[{"product_id":"human-ada-adenosine-deaminase-elisa-kit-picokine-bhe21001058","title":"Human ADA\/Adenosine Deaminase ELISA Kit PicoKine®","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAlso known as:\u003c\/strong\u003e Adenosine deaminase, 3.5.4.4, Adenosine aminohydrolase, ADA, ADA1.\u003c\/p\u003e\u003cp\u003eHuman \u003cstrong\u003eADA\/Adenosine Deaminase\u003c\/strong\u003e (\u003cstrong\u003eADA\u003c\/strong\u003e) is a commonly measured biological analyte that can provide insight into cellular state and tissue physiology. This target is frequently investigated in \u003cstrong\u003eMolecular \u0026amp; Cellular Biology\u003c\/strong\u003e research contexts. As with many protein targets, abundance can be influenced by transcriptional regulation, secretion or shedding, proteolytic processing, and clearance. Quantitative measurement is often used to connect molecular changes with phenotypes such as stress responses, immune activation, differentiation, or tissue remodeling.\u003c\/p\u003e\u003ch2\u003eBiological context and interpretation\u003c\/h2\u003e\u003cp\u003eProtein-level readouts complement nucleic-acid measurements by reflecting post-transcriptional control and protein stability. Depending on the model system, changes may be transient or sustained, and may represent direct pathway engagement or secondary effects. When interpreting results, consider sample matrix effects, timing relative to stimulation or treatment, and whether complexes or modified forms of the analyte may be present.\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eComparative quantification:\u003c\/strong\u003e Supports analysis across experimental groups, time points, or dose ranges.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePathway context:\u003c\/strong\u003e Useful as part of a broader marker panel to triangulate biological mechanisms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eModel characterization:\u003c\/strong\u003e Helps profile baseline vs perturbed states in cells, tissues, or biofluids.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eRelated pathways and interacting partners\u003c\/h2\u003e\u003cp\u003eFor many targets, interpretability improves when measured alongside biologically connected markers (e.g., upstream regulators, downstream effectors, and cell-type indicators). Designing panels around a pathway hypothesis can help distinguish primary pathway activation from general stress or inflammation.\u003c\/p\u003e","brand":"Boster Bio","offers":[{"title":"96 wells\/kit, with removable strips.","offer_id":52920845500781,"sku":"EK1446","price":499.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/ek1446_86ed42c8-4af6-4ded-9123-c251679e7df5.png?v=1769078012"},{"product_id":"adalimumab-humira-pharmacokinetic-elisa-bhe18300001","title":"Adalimumab (Humira) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdalimumab (Humira) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Adalimumab (Humira) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Adalimumab (Humira) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Adalimumab (Humira) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693544301,"sku":"EL-1611-011-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3.jpg?v=1769074193"},{"product_id":"bevacizumab-avastin-pharmacokinetic-elisa-bhe18300002","title":"Bevacizumab (Avastin) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eBevacizumab (Avastin) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Bevacizumab (Avastin) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Bevacizumab (Avastin) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Bevacizumab (Avastin) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693577069,"sku":"EL-1611-021-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_72adf560-2dda-44be-a977-e069e492b0b4.jpg?v=1769074193"},{"product_id":"cetuximab-erbitux-pharmacokinetic-elisa-bhe18300003","title":"Cetuximab (Erbitux) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eCetuximab (Erbitux) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Cetuximab (Erbitux) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Cetuximab (Erbitux) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Cetuximab (Erbitux) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693609837,"sku":"EL-1611-031-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_c87b9703-3d3b-4aa3-aec2-5757c628bf2b.jpg?v=1769074193"},{"product_id":"etanercept-enbrel-pharmacokinetic-elisa-bhe18300004","title":"Etanercept (Enbrel) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eEtanercept (Enbrel) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Etanercept (Enbrel) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Etanercept (Enbrel) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Etanercept (Enbrel) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693642605,"sku":"EL-1611-051-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_90308f58-4509-4410-ad2f-9d3e9042efdd.jpg?v=1769074193"},{"product_id":"infliximab-remicade-pharmacokinetic-elisa-bhe18300005","title":"Infliximab (Remicade) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eInfliximab (Remicade) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Infliximab (Remicade) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Infliximab (Remicade) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Infliximab (Remicade) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693675373,"sku":"EL-1611-091-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_1e3c2d85-2ff6-4956-bd07-a287764fe75c.jpg?v=1769074194"},{"product_id":"natalizumab-tysabri-pharmacokinetic-elisa-bhe18300006","title":"Natalizumab (Tysabri) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eNatalizumab (Tysabri) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Natalizumab (Tysabri) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Natalizumab (Tysabri) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Natalizumab (Tysabri) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693708141,"sku":"EL-1611-141-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_0bfb53bf-c4b5-492a-b4fc-42d7766e9096.jpg?v=1769074194"},{"product_id":"omalizumab-xolair-pharmacokinetic-elisa-bhe18300007","title":"Omalizumab (Xolair) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eOmalizumab (Xolair) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Omalizumab (Xolair) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Omalizumab (Xolair) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Omalizumab (Xolair) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693740909,"sku":"EL-1611-152-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_7627450f-efda-4751-9c58-c02a305d3739.jpg?v=1769074194"},{"product_id":"rituximab-rituxan-pharmacokinetic-elisa-bhe18300008","title":"Rituximab (Rituxan) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eRituximab (Rituxan) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Rituximab (Rituxan) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Rituximab (Rituxan) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Rituximab (Rituxan) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693773677,"sku":"EL-1611-181-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_4441adfe-54f5-47ae-8d3c-54d337cbe2ab.jpg?v=1769074195"},{"product_id":"trastuzumab-herceptin-pharmacokinetic-elisa-bhe18300009","title":"Trastuzumab (Herceptin) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTrastuzumab (Herceptin) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Trastuzumab (Herceptin) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Trastuzumab (Herceptin) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Trastuzumab (Herceptin) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693806445,"sku":"EL-1611-201-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_64fccc38-df7a-4964-8491-1be9c359fbb1.jpg?v=1769074195"},{"product_id":"tocilizumab-actemra-pharmacokinetic-elisa-bhe18300010","title":"Tocilizumab (Actemra) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTocilizumab (Actemra) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Tocilizumab (Actemra) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Tocilizumab (Actemra) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Tocilizumab (Actemra) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693839213,"sku":"EL-1611-202-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_930d673a-3aa8-4135-a952-760e6b41c248.jpg?v=1769074195"},{"product_id":"rituximab-rituxan-immunogenicity-elisa-bhe18300011","title":"Rituximab (Rituxan) Immunogenicity ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eRituximab (Rituxan) Immunogenicity\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Rituximab (Rituxan) Immunogenicity in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Rituximab (Rituxan) Immunogenicity may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Rituximab (Rituxan) Immunogenicity participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693871981,"sku":"EL-141-181-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_e82218ea-48f0-464f-8227-a01d014d87bc.jpg?v=1769074196"},{"product_id":"trastuzumab-herceptin-immunogenicity-elisa-bhe18300012","title":"Trastuzumab (Herceptin) Immunogenicity ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTrastuzumab (Herceptin) Immunogenicity\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Trastuzumab (Herceptin) Immunogenicity in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Trastuzumab (Herceptin) Immunogenicity may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Trastuzumab (Herceptin) Immunogenicity participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950693904749,"sku":"EL-141-201-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_0f51ce42-2b3b-4f37-9884-8c03c5923d8b.jpg?v=1769074196"},{"product_id":"human-growth-hormone-hgh-somatropin-pharmacokinetic-elisa-bhe18300018","title":"Human growth hormone (hGH) (Somatropin) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eHuman growth hormone (hGH) (Somatropin) Pharmacokinetic\u003c\/strong\u003e is a biological molecule commonly studied in life science research. Hormones and peptide mediators support systemic communication across organs and physiological states.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Human growth hormone (hGH) (Somatropin) Pharmacokinetic in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Human growth hormone (hGH) (Somatropin) Pharmacokinetic may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Human growth hormone (hGH) (Somatropin) Pharmacokinetic participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950694134125,"sku":"EL-1611-878-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_189dfff3-2037-4fa6-9ed1-78ba9e95be7b.jpg?v=1769074198"},{"product_id":"filgrastim-gcsf-pharmacokinetic-elisa-el-1611-73196-bhe18300019","title":"Filgrastim (GCSF) Pharmacokinetic ELISA (RUO)","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eFilgrastim (GCSF) Pharmacokinetic ELISA | EL-1611-73196\u003c\/strong\u003e is a biological molecule commonly studied in life science research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.\u003c\/p\u003e\u003ch2\u003eBiological context\u003c\/h2\u003e\u003cp\u003eResearchers often monitor Filgrastim (GCSF) Pharmacokinetic ELISA | EL-1611-73196 in Serum Plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.\u003c\/p\u003e\u003ch2\u003eInterpreting changes in measured levels\u003c\/h2\u003e\u003cp\u003eDepending on sample matrix and study design, increases or decreases in Filgrastim (GCSF) Pharmacokinetic ELISA | EL-1611-73196 may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.\u003c\/p\u003e\u003ch2\u003eWhy quantitative measurements are widely used\u003c\/h2\u003e\u003cp\u003eQuantitative immunoassays are widely used for measuring proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that Filgrastim (GCSF) Pharmacokinetic ELISA | EL-1611-73196 participates in.\u003c\/p\u003e","brand":"AffinityImmuno Inc.","offers":[{"title":"96 wells × 1","offer_id":52950694199661,"sku":"EL-1611-73196-96WELLSX1","price":859.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/AffinityImmuno-Product-3_72e24776-0681-4569-a6fa-73700985af70.jpg?v=1769074198"},{"product_id":"human-adenosine-deaminase-ada-elisa-kit-bhe12102456","title":"Human Adenosine Deaminase, ADA ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdenosine Deaminase (ADA)\u003c\/strong\u003e is a molecular target commonly studied in epigenetics and nuclear signaling research. This molecule is commonly investigated as part of broader signaling, regulatory, or homeostatic networks.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eUniProt\u003c\/strong\u003e: P00813\u003c\/p\u003e\u003ch2\u003eBiological role and pathway context\u003c\/h2\u003e\u003cp\u003eIn the literature, Adenosine Deaminase (ADA) is frequently examined in relation to mechanistic biology studies, biomarker-focused profiling, and disease-model research. Depending on the model system, changes in abundance can be associated with shifts in signaling state, cellular composition, or tissue physiology.\u003c\/p\u003e\u003ch2\u003eExpression and regulation\u003c\/h2\u003e\u003cp\u003eExpression of Adenosine Deaminase (ADA) can vary across tissues and cell types and may change under conditions such as immune activation, stress responses, injury, infection, or metabolic perturbation. Reported regulation may involve transcriptional control as well as post-translational processes that influence stability, localization, processing, or secretion.\u003c\/p\u003e\u003ch2\u003eResearch and disease relevance\u003c\/h2\u003e\u003cp\u003eAdenosine Deaminase (ADA) has been reported as a useful readout in studies of physiological regulation and disease-associated processes. These observations make it relevant for hypothesis-driven research and biomarker exploration, while interpretation should remain grounded in the specific species, sample matrix, and study design.\u003c\/p\u003e\u003ch2\u003eInterpreting concentration measurements\u003c\/h2\u003e\u003cp\u003eMeasured levels of Adenosine Deaminase (ADA) can reflect multiple biological factors, including production rate, turnover, compartmental distribution, and sample composition. As a result, conclusions are often supported by considering broader pathway context and complementary readouts rather than relying on a single analyte alone.\u003c\/p\u003e\u003ch2\u003eNomenclature\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdenosine Deaminase (ADA)\u003c\/strong\u003e may also be referred to as \u003cstrong\u003eADA\u003c\/strong\u003e, \u003cstrong\u003eAdenosine aminohydrolase\u003c\/strong\u003e, and \u003cstrong\u003eAdenosine deaminase\u003c\/strong\u003e in publications and databases. Nomenclature differences and species context can influence how results are compared across studies.\u003c\/p\u003e","brand":"Bioassay Technology Laboratory","offers":[{"title":"96T","offer_id":52952462262637,"sku":"E0777Hu-96T","price":458.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/E0777Hu.jpg?v=1769146080"},{"product_id":"mouse-adenosine-deaminase-ada-elisa-kit-bhe12109442","title":"Mouse Adenosine Deaminase, ADA ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdenosine Deaminase (ADA)\u003c\/strong\u003e is a molecular target commonly studied in epigenetics and nuclear signaling research. This molecule is commonly investigated as part of broader signaling, regulatory, or homeostatic networks.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eUniProt\u003c\/strong\u003e: P03958\u003c\/p\u003e\u003ch2\u003eBiological role and pathway context\u003c\/h2\u003e\u003cp\u003eIn the literature, Adenosine Deaminase (ADA) is frequently examined in relation to mechanistic biology studies, biomarker-focused profiling, and disease-model research. Depending on the model system, changes in abundance can be associated with shifts in signaling state, cellular composition, or tissue physiology.\u003c\/p\u003e\u003ch2\u003eExpression and regulation\u003c\/h2\u003e\u003cp\u003eExpression of Adenosine Deaminase (ADA) can vary across tissues and cell types and may change under conditions such as immune activation, stress responses, injury, infection, or metabolic perturbation. Reported regulation may involve transcriptional control as well as post-translational processes that influence stability, localization, processing, or secretion.\u003c\/p\u003e\u003ch2\u003eResearch and disease relevance\u003c\/h2\u003e\u003cp\u003eAdenosine Deaminase (ADA) has been reported as a useful readout in studies of physiological regulation and disease-associated processes. These observations make it relevant for hypothesis-driven research and biomarker exploration, while interpretation should remain grounded in the specific species, sample matrix, and study design.\u003c\/p\u003e\u003ch2\u003eInterpreting concentration measurements\u003c\/h2\u003e\u003cp\u003eMeasured levels of Adenosine Deaminase (ADA) can reflect multiple biological factors, including production rate, turnover, compartmental distribution, and sample composition. As a result, conclusions are often supported by considering broader pathway context and complementary readouts rather than relying on a single analyte alone.\u003c\/p\u003e\u003ch2\u003eNomenclature\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdenosine Deaminase (ADA)\u003c\/strong\u003e may also be referred to as \u003cstrong\u003eADA\u003c\/strong\u003e, \u003cstrong\u003eAdenosine aminohydrolase\u003c\/strong\u003e, and \u003cstrong\u003eAdenosine deaminase\u003c\/strong\u003e in publications and databases. Nomenclature differences and species context can influence how results are compared across studies.\u003c\/p\u003e","brand":"Bioassay Technology Laboratory","offers":[{"title":"96T","offer_id":52952626725229,"sku":"E1600Mo-96T","price":458.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/E1600Mo.jpg?v=1769147093"},{"product_id":"rat-ada-adenosine-deaminase-elisa-kit-bhe152011205","title":"Rat ADA(Adenosine Deaminase) ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eRat\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Rat ADA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Rat ADA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Rat ADA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Rat ADA in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 0.16-10 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 0.071 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52964646912365,"sku":"ELK9467-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52964646945133,"sku":"ELK9467-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52964646977901,"sku":"ELK9467-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_daf9c04c-4278-4452-8b74-cc93e6d0e6a5.jpg?v=1771841199"},{"product_id":"horse-ada-adenosine-deaminase-elisa-kit-bhe152011565","title":"Horse ADA(Adenosine Deaminase) ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eHorse\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Horse ADA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Horse ADA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Horse ADA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Horse ADA in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 0.16-10 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 0.068 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52964686528877,"sku":"ELK9823-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52964686561645,"sku":"ELK9823-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52964686594413,"sku":"ELK9823-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_200954ff-7fd6-46f2-9522-4d0f1bcc6dfd.jpg?v=1771841445"},{"product_id":"human-adalimumab-elisa-kit-bhe152011568","title":"Human Adalimumab ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAdalimumab\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eAdalimumab\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eHuman\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human Adalimumab. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Adalimumab. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human Adalimumab, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Adalimumab in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: serum, plasma.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 15.63-1000 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 4.93 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52964686889325,"sku":"ELK9826-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52964686922093,"sku":"ELK9826-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52964686954861,"sku":"ELK9826-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_bfc9585d-9cf1-4f0e-8e0c-60d4d606c49c.jpg?v=1771841448"},{"product_id":"human-ada-adenosine-deaminase-elisa-kit-bhe15203756","title":"Human ADA(Adenosine Deaminase) ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eHuman\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human ADA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human ADA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human ADA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human ADA in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 0.16-10 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 0.066 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52965379604845,"sku":"ELK1970-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52965379637613,"sku":"ELK1970-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52965379670381,"sku":"ELK1970-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_e7f8e256-4bc8-47ca-9b37-886f3a517330.jpg?v=1771843110"},{"product_id":"chicken-ada-adenosine-deaminase-elisa-kit-bhe15207908","title":"Chicken ADA(Adenosine Deaminase) ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eChicken\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Chicken ADA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Chicken ADA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Chicken ADA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Chicken ADA in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 0.16-10 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 0.067 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52965907628397,"sku":"ELK8740-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52965907661165,"sku":"ELK8740-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52965907693933,"sku":"ELK8740-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_6d175d3d-2e81-4f59-90ef-605237e1db27.jpg?v=1771845287"},{"product_id":"human-infliximab-elisa-kit-bhe15208509","title":"Human Infliximab ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eInfliximab\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eInfliximab\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eHuman\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human Infliximab. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Infliximab. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human Infliximab, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Infliximab in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 4.69-300 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 1.77 ng\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52965967921517,"sku":"ELK0764-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52965967954285,"sku":"ELK0764-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52965967987053,"sku":"ELK0764-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_8c2fc0ea-d285-4061-aaae-927412f45f7e.jpg?v=1771845602"},{"product_id":"mouse-ada-adenosine-deaminase-elisa-kit-bhe15210421","title":"Mouse ADA(Adenosine Deaminase) ELISA Kit","description":"\u003ch3\u003eScientific background\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e is a biologically relevant protein marker measured to support mechanistic studies and biomarker discovery (context dependent).\u003c\/p\u003e\u003cp\u003eProtein concentrations can change due to secretion, degradation, cell composition shifts, or post-transcriptional regulation, so ELISA readouts often add information beyond gene expression alone.\u003c\/p\u003e\u003cp\u003eQuantitative measurements help compare groups and time points using standardized curves and can be interpreted alongside phenotype and pathway-specific readouts.\u003c\/p\u003e\u003ch3\u003eWhy it matters\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuantify \u003cstrong\u003eADA (Adenosine Deaminase)\u003c\/strong\u003e to compare biological changes across conditions, doses, or time points.\u003c\/li\u003e\n\u003cli\u003eGenerate concentration data from a standard curve to support biomarker and mechanistic studies.\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eHow the ELISA works\u003c\/h3\u003e\u003cp\u003eDesigned for \u003cstrong\u003eMouse\u003c\/strong\u003e samples, this kit uses a \u003cstrong\u003eThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Mouse ADA. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Mouse ADA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Mouse ADA, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Mouse ADA in the samples is then determined by comparing the OD of the samples to the standard curve.\u003c\/strong\u003e. After binding and washing, signal is converted to concentration using a standard curve.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSample types\u003c\/strong\u003e: Serum, plasma, tissue homogenates and other biological fluids.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetection range\u003c\/strong\u003e: 78.13-5000 pg\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSensitivity\/LoD\u003c\/strong\u003e: 19.36 pg\/mL\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAssay time\u003c\/strong\u003e: 3.5h\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"ELK Biotechnology","offers":[{"title":"96 T","offer_id":52966198477165,"sku":"ELK9943-96T","price":595.4,"currency_code":"USD","in_stock":true},{"title":"48 T","offer_id":52966198509933,"sku":"ELK9943-48T","price":416.0,"currency_code":"USD","in_stock":true},{"title":"96 T X 5","offer_id":52966198542701,"sku":"ELK9943-96TX5","price":2531.1,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/1h1qbq4v21p4717oo1b_a2e76d7c-8b23-4f33-9489-0053c6900a85.jpg?v=1771846645"},{"product_id":"bevacizumab-avastin-elisa-kit-bhe10809169","title":"Bevacizumab (Avastin) ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003euniversal Bevacizumab (Avastin)\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Bevacizumab is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Bevacizumab can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eBevacizumab (Avastin)\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAvastin\u003c\/strong\u003e and \u003cstrong\u003eBevacizumab\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Bevacizumab relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Bevacizumab levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eBevacizumab has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975459565933,"sku":"EU2594-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_67fe0b02-b8a0-48bf-a497-48d4fb82ab3c.jpg?v=1769599644"},{"product_id":"human-adalimumab-elisa-kit-bhe10809661","title":"Human Adalimumab ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Adalimumab\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Adalimumab is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Adalimumab can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAdalimumab\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAdalimumab\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Adalimumab relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Adalimumab levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAdalimumab has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975475097965,"sku":"EH5106-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_c00bc751-d8de-4599-9acd-aa9faf548332.jpg?v=1769599787"},{"product_id":"human-anti-adalimumab-antibody-elisa-kit-bhe10809664","title":"Human Anti-Adalimumab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-Adalimumab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-Adalimumab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-Adalimumab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-Adalimumab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAdalimumab antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-Adalimumab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-Adalimumab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-Adalimumab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975475196269,"sku":"EH5107-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_b54da31e-2119-4d6f-9339-58e60c951402.jpg?v=1769599788"},{"product_id":"human-anti-bevacizumab-avastin-antibody-elisa-kit-bhe10809665","title":"Human anti-Bevacizumab (Avastin) antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman anti-Bevacizumab (Avastin) antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of anti-Bevacizumab (Avastin) antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of anti-Bevacizumab (Avastin) antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eanti-Bevacizumab (Avastin) antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eBevacizumab antibody\u003c\/strong\u003e and \u003cstrong\u003eAvastin antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how anti-Bevacizumab (Avastin) antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in anti-Bevacizumab (Avastin) antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eanti-Bevacizumab (Avastin) antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975475229037,"sku":"EH5110-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_c93bb748-8419-4091-9766-298a05affe60.jpg?v=1769599788"},{"product_id":"human-anti-adalimumab-antibody-elisa-kit-bhe10809839","title":"Human Anti-Adalimumab antibody ELISA kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-Adalimumab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-Adalimumab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-Adalimumab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-Adalimumab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAnti-Adalimumab\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-Adalimumab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-Adalimumab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-Adalimumab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975481225581,"sku":"EH5126-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_f330b7ac-f5d5-4d1c-8d8c-2e537a006c0a.jpg?v=1769599838"},{"product_id":"human-trastuzumab-elisa-kit-bhe10809909","title":"Human Trastuzumab ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Trastuzumab\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Trastuzumab is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Trastuzumab can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTrastuzumab\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eTrastuzumab\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Trastuzumab relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Trastuzumab levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eTrastuzumab has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975483650413,"sku":"EH5144-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_331907be-8059-4768-aecf-9f8cc30aacc3.jpg?v=1769599856"},{"product_id":"infliximab-elisa-kit-bhe10809996","title":"Infliximab ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003euniversal Infliximab (TNF)\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Infliximab is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Infliximab can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eInfliximab (TNF)\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eTumor necrosis factor\u003c\/strong\u003e, \u003cstrong\u003eCachectin\u003c\/strong\u003e, and \u003cstrong\u003eTNF-alpha\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Infliximab relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Infliximab levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eInfliximab has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975486533997,"sku":"EU3589-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_6523dbc7-fad6-45cf-9d5f-e387dfa72736.jpg?v=1769599878"},{"product_id":"anti-infliximab-antibody-elisa-kit-bhe10809997","title":"Anti-Infliximab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003euniversal Anti-Infliximab antibody (TNF)\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-Infliximab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-Infliximab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-Infliximab antibody (TNF)\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eTumor necrosis factor\u003c\/strong\u003e, \u003cstrong\u003eCachectin\u003c\/strong\u003e, and \u003cstrong\u003eTNF-alpha\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-Infliximab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-Infliximab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-Infliximab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975486566765,"sku":"EU3590-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_af47b732-66d8-4512-958b-8a7add1b8697.jpg?v=1769599879"},{"product_id":"human-anti-trastuzumab-antibody-elisa-kit-bhe10812100","title":"Human Anti-trastuzumab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-trastuzumab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-trastuzumab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-trastuzumab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-trastuzumab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAnti-trastuzumab antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-trastuzumab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-trastuzumab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-trastuzumab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975563506029,"sku":"EH5252-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_62ef1027-7c3e-4bc6-8a6b-ed37eac1ccac.jpg?v=1769600628"},{"product_id":"human-anti-trastuzumab-antibody-elisa-kit-bhe10812101","title":"Human Anti-trastuzumab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-trastuzumab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-trastuzumab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-trastuzumab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-trastuzumab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAnti-trastuzumab antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-trastuzumab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-trastuzumab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-trastuzumab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975563538797,"sku":"EH5252-CM-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_2e38ec1f-251c-440a-b0cc-eefa7670c660.jpg?v=1769600629"},{"product_id":"human-anti-rituximab-antibody-elisa-kit-bhe10812135","title":"Human Anti-Rituximab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-Rituximab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-Rituximab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-Rituximab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-Rituximab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAnti-Rituximab\u003c\/strong\u003e and \u003cstrong\u003eRituximab antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-Rituximab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-Rituximab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-Rituximab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975564685677,"sku":"EH5295-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_c7ef6db9-36eb-4f71-b824-a3038dc3c3ec.jpg?v=1769600648"},{"product_id":"human-ustekinumab-elisa-kit-bhe10812158","title":"Human Ustekinumab ELISA kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Ustekinumab (IL)\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Ustekinumab is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Ustekinumab can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eUstekinumab (IL)\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eUstekinumab\u003c\/strong\u003e and \u003cstrong\u003eAnti-Human IL-12\/IL-23, Human Antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Ustekinumab relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Ustekinumab levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eUstekinumab has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975565504877,"sku":"EH5320-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_6b621dae-de21-4066-b852-d6cebfea7923.jpg?v=1769600657"},{"product_id":"human-anti-ustekinumab-antibody-elisa-kit-bhe10812159","title":"Human Anti-Ustekinumab antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-Ustekinumab antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-Ustekinumab antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-Ustekinumab antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-Ustekinumab antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eUstekinumab antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-Ustekinumab antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-Ustekinumab antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-Ustekinumab antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975565537645,"sku":"EH5321-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_5011c1f3-e03a-453a-827b-74c2edffe3ea.jpg?v=1769600658"},{"product_id":"human-anti-t-dxd-trastuzumab-deruxtecan-antibody-elisa-kit-bhe10812190","title":"Human Anti-T-DXd (trastuzumab deruxtecan) antibody ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003ehuman Anti-T-DXd (trastuzumab deruxtecan) antibody\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Anti-T-DXd (trastuzumab deruxtecan) antibody is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Anti-T-DXd (trastuzumab deruxtecan) antibody can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eAnti-T-DXd (trastuzumab deruxtecan) antibody\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eAnti-T-DXd\u003c\/strong\u003e, \u003cstrong\u003eAnti-trastuzumab deruxtecan\u003c\/strong\u003e, and \u003cstrong\u003etrastuzumab deruxtecan antibody\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Anti-T-DXd (trastuzumab deruxtecan) antibody relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Anti-T-DXd (trastuzumab deruxtecan) antibody levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eAnti-T-DXd (trastuzumab deruxtecan) antibody has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975567962477,"sku":"EH5357-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_77dd0fd2-5d83-4a20-9b2a-86976ced0df6.jpg?v=1769600671"},{"product_id":"trastuzumab-emtansine-elisa-kit-bhe10812706","title":"Trastuzumab Emtansine ELISA Kit","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003euniversal Trastuzumab Emtansine (PRO132365)\u003c\/strong\u003e is a molecular target commonly studied in biomedical research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.\u003c\/p\u003e\u003ch2\u003eBiological role and mechanism\u003c\/h2\u003e\u003cp\u003eThe biological role of Trastuzumab Emtansine is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.\u003c\/p\u003e\u003cp\u003eExpression and abundance of Trastuzumab Emtansine can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.\u003c\/p\u003e\u003ch2\u003eNomenclature and related terms\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTrastuzumab Emtansine (PRO132365)\u003c\/strong\u003e may also be referenced as \u003cstrong\u003eTrastuzumab Emtansine\u003c\/strong\u003e, \u003cstrong\u003eAdo-Trastuzumab emtansine\u003c\/strong\u003e, and \u003cstrong\u003ePRO132365\u003c\/strong\u003e in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).\u003c\/p\u003e\u003ch2\u003eWhy it matters in research\u003c\/h2\u003e\u003cul\u003e\n\u003cli\u003eUnderstanding how Trastuzumab Emtansine relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.\u003c\/li\u003e\n\u003cli\u003eInterpreting shifts in Trastuzumab Emtansine levels alongside other pathway components or complementary markers.\u003c\/li\u003e\n\u003cli\u003eConnecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eMolecular forms and interpretation\u003c\/h2\u003e\u003cp\u003eFor some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.\u003c\/p\u003e\u003ch2\u003eDisease and translational relevance\u003c\/h2\u003e\u003cp\u003eTrastuzumab Emtansine has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"96 T","offer_id":52975593488749,"sku":"EU2672-96T","price":520.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/elisa_e44e40ab-6873-4d0b-a397-6e1d17ad23f9.jpg?v=1769600828"},{"product_id":"recombinant-mouse-ada-adenosine-deaminase-protein-n-his-bhp21402077","title":"Recombinant Mouse ADA\/Adenosine deaminase Protein, N-His","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTarget identity:\u003c\/strong\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is a protein. It is typically cell-type and isoform dependent (intracellular or extracellular).\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is provided as a recombinant protein reagent for \u003cstrong\u003eresearch use only\u003c\/strong\u003e. Recombinant proteins are commonly used as defined molecular inputs in biochemical and cell-free systems, enabling controlled interrogation of binding, activity, and pathway-relevant interactions.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eProtein identity context:\u003c\/strong\u003e ADA (expression region Met1-Gln352; approx. molecular weight 42.14 kDa).\u003c\/p\u003e\u003ch2\u003eBiological significance and function\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is used in RUO research to interrogate molecular mechanisms, interaction networks, and pathway-linked phenotypes in experimental systems. This target is frequently explored in \u003cstrong\u003eMolecular \u0026amp; Cellular Biology\u003c\/strong\u003e research contexts.\u003c\/p\u003e\u003ch2\u003eMolecular characteristics\u003c\/h2\u003e\u003cp\u003eKey molecular attributes can influence binding behavior, stability, and assay background—especially for multimeric, disulfide-rich, or PTM-dependent targets.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpression system:\u003c\/strong\u003e E. coli\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpression region:\u003c\/strong\u003e Met1-Gln352\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 42.14 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;90%\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilized\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1 mM EDTA, 4% Trehalose, 1% Mannitol.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cstrong\u003ePost-translational considerations:\u003c\/strong\u003e Prokaryotic expression typically yields a non-glycosylated recombinant form. This is often appropriate for many intracellular proteins and binding studies, while disulfide-rich or PTM-dependent extracellular targets may behave differently when native PTMs are required.\u003c\/p\u003e\u003ch2\u003eExpression and purification strategy\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eExpression system:\u003c\/strong\u003e E. coli. Expression host selection can influence folding and PTM state, which may affect activity or binding in different assay formats.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePurification:\u003c\/strong\u003e Affinity-chromatography. Purification approach and formulation influence sample homogeneity and background signal in downstream biochemical measurements.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eEndotoxin consideration:\u003c\/strong\u003e Reported endotoxin level is Please contact with the lab for this information.; this parameter can matter when recombinant proteins are used in cell-based systems sensitive to innate immune activation.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eReconstitution:\u003c\/strong\u003e Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details..\u003c\/p\u003e\u003ch2\u003eResearch interpretation\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eResearch interpretation:\u003c\/strong\u003e Recombinant protein reagents support controlled experiments such as interaction mapping, assay calibration, and reconstitution studies with defined inputs. Interpreting outcomes typically benefits from pairing the primary readout with orthogonal markers that report pathway state and complex formation.\u003c\/p\u003e","brand":"Biohippo Inc","offers":[{"title":"100 ug","offer_id":53000849490285,"sku":"MF562012-100UG","price":311.0,"currency_code":"USD","in_stock":true},{"title":"1 mg","offer_id":53000849523053,"sku":"MF562012-1MG","price":1627.0,"currency_code":"USD","in_stock":true}]},{"product_id":"recombinant-human-ada-adenosine-deaminase-protein-n-his-sumo-bhp21403553","title":"Recombinant Human ADA\/Adenosine deaminase Protein, N-His-SUMO","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTarget identity:\u003c\/strong\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is a protein. It is typically cell-type and isoform dependent (intracellular or extracellular).\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is provided as a recombinant protein reagent for \u003cstrong\u003eresearch use only\u003c\/strong\u003e. Recombinant proteins are commonly used as defined molecular inputs in biochemical and cell-free systems, enabling controlled interrogation of binding, activity, and pathway-relevant interactions.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eProtein identity context:\u003c\/strong\u003e ADA (expression region Thr57-Leu363; approx. molecular weight 46.97 kDa).\u003c\/p\u003e\u003ch2\u003eBiological significance and function\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is used in RUO research to interrogate molecular mechanisms, interaction networks, and pathway-linked phenotypes in experimental systems. This target is frequently explored in \u003cstrong\u003eMolecular \u0026amp; Cellular Biology\u003c\/strong\u003e research contexts.\u003c\/p\u003e\u003ch2\u003eMolecular characteristics\u003c\/h2\u003e\u003cp\u003eKey molecular attributes can influence binding behavior, stability, and assay background—especially for multimeric, disulfide-rich, or PTM-dependent targets.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpression system:\u003c\/strong\u003e E. coli\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpression region:\u003c\/strong\u003e Thr57-Leu363\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 46.97 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;90%\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilized\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1 mM EDTA, 4% Trehalose, 1% Mannitol.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cstrong\u003ePost-translational considerations:\u003c\/strong\u003e Prokaryotic expression typically yields a non-glycosylated recombinant form. This is often appropriate for many intracellular proteins and binding studies, while disulfide-rich or PTM-dependent extracellular targets may behave differently when native PTMs are required.\u003c\/p\u003e\u003ch2\u003eExpression and purification strategy\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eExpression system:\u003c\/strong\u003e E. coli. Expression host selection can influence folding and PTM state, which may affect activity or binding in different assay formats.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePurification:\u003c\/strong\u003e Affinity-chromatography. Purification approach and formulation influence sample homogeneity and background signal in downstream biochemical measurements.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eEndotoxin consideration:\u003c\/strong\u003e Reported endotoxin level is Please contact with the lab for this information.; this parameter can matter when recombinant proteins are used in cell-based systems sensitive to innate immune activation.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eReconstitution:\u003c\/strong\u003e Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details..\u003c\/p\u003e\u003ch2\u003eResearch interpretation\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eResearch interpretation:\u003c\/strong\u003e Recombinant protein reagents support controlled experiments such as interaction mapping, assay calibration, and reconstitution studies with defined inputs. Interpreting outcomes typically benefits from pairing the primary readout with orthogonal markers that report pathway state and complex formation.\u003c\/p\u003e","brand":"Biohippo Inc","offers":[{"title":"100 ug","offer_id":53000951300461,"sku":"HF562022-100UG","price":311.0,"currency_code":"USD","in_stock":true},{"title":"1 mg","offer_id":53000951333229,"sku":"HF562022-1MG","price":1627.0,"currency_code":"USD","in_stock":true}]},{"product_id":"recombinant-human-ada-protein-n-his-bhp21409503","title":"Recombinant Human ADA Protein, N-His","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eTarget identity:\u003c\/strong\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is a protein. It is typically cell-type and isoform dependent (intracellular or extracellular).\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is provided as a recombinant protein reagent for \u003cstrong\u003eresearch use only\u003c\/strong\u003e. Recombinant proteins are commonly used as defined molecular inputs in biochemical and cell-free systems, enabling controlled interrogation of binding, activity, and pathway-relevant interactions.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eProtein identity context:\u003c\/strong\u003e ADA (expression region Lys11-Val280; approx. molecular weight 32.47 kDa).\u003c\/p\u003e\u003ch2\u003eBiological significance and function\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is used in RUO research to interrogate molecular mechanisms, interaction networks, and pathway-linked phenotypes in experimental systems. This target is frequently explored in \u003cstrong\u003eMolecular \u0026amp; Cellular Biology\u003c\/strong\u003e research contexts.\u003c\/p\u003e\u003ch2\u003eMolecular characteristics\u003c\/h2\u003e\u003cp\u003eKey molecular attributes can influence binding behavior, stability, and assay background—especially for multimeric, disulfide-rich, or PTM-dependent targets.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpression system:\u003c\/strong\u003e E. coli\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpression region:\u003c\/strong\u003e Lys11-Val280\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular weight:\u003c\/strong\u003e 32.47 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e \u0026gt;90%\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilized\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1 mM EDTA, 4% Trehalose, 1% Mannitol.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cstrong\u003ePost-translational considerations:\u003c\/strong\u003e Prokaryotic expression typically yields a non-glycosylated recombinant form. This is often appropriate for many intracellular proteins and binding studies, while disulfide-rich or PTM-dependent extracellular targets may behave differently when native PTMs are required.\u003c\/p\u003e\u003ch2\u003eExpression and purification strategy\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eExpression system:\u003c\/strong\u003e E. coli. Expression host selection can influence folding and PTM state, which may affect activity or binding in different assay formats.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePurification:\u003c\/strong\u003e Affinity-chromatography. Purification approach and formulation influence sample homogeneity and background signal in downstream biochemical measurements.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eEndotoxin consideration:\u003c\/strong\u003e Reported endotoxin level is Please contact with the lab for this information.; this parameter can matter when recombinant proteins are used in cell-based systems sensitive to innate immune activation.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eReconstitution:\u003c\/strong\u003e Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details..\u003c\/p\u003e\u003ch2\u003eResearch interpretation\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eResearch interpretation:\u003c\/strong\u003e Recombinant protein reagents support controlled experiments such as interaction mapping, assay calibration, and reconstitution studies with defined inputs. Interpreting outcomes typically benefits from pairing the primary readout with orthogonal markers that report pathway state and complex formation.\u003c\/p\u003e","brand":"Biohippo Inc","offers":[{"title":"100 ug","offer_id":53001846096237,"sku":"HF562012-100UG","price":311.0,"currency_code":"USD","in_stock":true},{"title":"1 mg","offer_id":53001846129005,"sku":"HF562012-1MG","price":1627.0,"currency_code":"USD","in_stock":true}]},{"product_id":"recombinant-human-ada-bhp10800350","title":"Recombinant Human ADA","description":"\u003ch2\u003eBackground\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is used in \u003cstrong\u003eresearch use only (RUO)\u003c\/strong\u003e settings as a defined recombinant protein reagent. Bench researchers commonly leverage recombinant proteins to create controlled experimental conditions for mechanistic studies, assay development, interaction mapping, and quantitative benchmarking across model systems.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eAlso known as:\u003c\/strong\u003e ada, ADA_HUMAN, ADA1, Adenosine aminohydrolase, Adenosine deaminase.\u003c\/p\u003e\u003ch2\u003eBiological significance and function\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eADA\u003c\/strong\u003e is frequently used in RUO studies focused on \u003cstrong\u003emetabolic pathway regulation, energy homeostasis, and cellular bioenergetics\u003c\/strong\u003e. Recombinant protein reagents help researchers build defined systems for biochemical characterization, binding assays, and assay development where reproducibility and traceability matter.\u003c\/p\u003e\u003cp\u003eMechanistically, researchers often analyze how ADA participates in pathway networks through molecular interactions, localization, and regulated activity. Depending on the target class, this can involve receptor-mediated signaling, enzymatic catalysis, complex assembly, or structural organization that shapes downstream cellular phenotypes.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eResearch relevance:\u003c\/strong\u003e RUO studies frequently connect ADA to perturbations such as immune stimulation, stress signaling, differentiation cues, metabolic remodeling, or engineered genetic modulation—then interpret downstream readouts using complementary pathway markers.\u003c\/p\u003e\u003ch2\u003eMolecular characteristics\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eMolecular features matter in RUO experiments:\u003c\/strong\u003e domain boundaries, oligomerization state, and PTM sensitivity can influence binding behavior, stability, and functional readouts in vitro.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eSource species:\u003c\/strong\u003e Human\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eConstruct \/ expression region:\u003c\/strong\u003e aa 1-363\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eApprox. molecular weight:\u003c\/strong\u003e 40.8 kDa\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurity:\u003c\/strong\u003e Greater than 90% as determined by SDS-PAGE.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eForm:\u003c\/strong\u003e Lyophilized powder\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Lyophilized from a 0.2 μm filtered solution of 10 mM Hepes, 150 mM NaCl with 5% trehalose, pH 7.4.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReconstitution:\u003c\/strong\u003e Centrifuge the vial before opening, reconstitute in sterile distilled water to a concentration of 0.1-1 mg\/ml by gently pipetting 2-3 times, don't vortex.\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cstrong\u003ePTM considerations:\u003c\/strong\u003e Catalytic proteins can be sensitive to \u003cstrong\u003ecofactors\u003c\/strong\u003e, \u003cstrong\u003eredox state\u003c\/strong\u003e, and site-specific PTMs that tune activity or interactions in vivo. Whether those PTMs are present depends on expression host and construct design. Prokaryotic expression typically yields non-glycosylated protein; consider whether eukaryotic PTMs are required for your assay context.\u003c\/p\u003e\u003ch2\u003eExpression and purification strategy\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eExpression system:\u003c\/strong\u003e This protein is produced in a \u003cstrong\u003eprokaryotic (E. coli)\u003c\/strong\u003e system, which typically yields a defined, non-glycosylated form. This can be advantageous for mechanistic studies, binding assays, and antigen\/standard use where mammalian PTMs are not required.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003ePurification transparency (research credibility):\u003c\/strong\u003e In research-grade recombinant protein production, constructs are commonly purified via affinity and polishing steps (e.g., chromatography) to reduce contaminants and improve batch-to-batch consistency. When present, affinity tags (e.g., His\/GST\/Fc) can simplify purification; tag presence or removal can influence certain binding or structural assays.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eForm and handling context:\u003c\/strong\u003e Lyophilized proteins are frequently used in RUO labs to support stability during storage and shipment, while formulation components and reconstitution conditions can impact solubility and aggregation—important considerations when comparing studies across publications.\u003c\/p\u003e\u003ch2\u003eResearch interpretation\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eResearch interpretation:\u003c\/strong\u003e Catalytic readouts are often context-dependent, influenced by cofactors, partner proteins, and PTM state. recombinant \u003cstrong\u003eADA\u003c\/strong\u003e is commonly integrated with complementary pathway markers to interpret whether observed changes reflect altered activity, abundance, or complex formation.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eUsing recombinant protein as a defined reagent:\u003c\/strong\u003e recombinant ADA is commonly used as a quantitative input for assay calibration, antibody\/ligand binding studies, pathway reconstitution, and controlled perturbation experiments. Researchers often consider isoforms, fragments, or construct boundaries when comparing results across studies.\u003c\/p\u003e","brand":"Fine Test","offers":[{"title":"50 ug","offer_id":53013907374445,"sku":"P0627-50UG","price":455.0,"currency_code":"USD","in_stock":true},{"title":"200 ug","offer_id":53013907407213,"sku":"P0627-200UG","price":910.0,"currency_code":"USD","in_stock":true},{"title":"1 mg","offer_id":53013907439981,"sku":"P0627-1MG","price":2730.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/E8_9B_8B_E7_99_BD_5945b5fb-a697-4a1b-a956-d2f937b0be7d.jpg?v=1770539367"},{"product_id":"aav-cmv-sacas9-u6-sgrna-scramble-aav-serotype-1-bhv21500118","title":"AAV-CMV-saCas9-U6-sgRNA(Scramble) (AAV Serotype 1)","description":"\u003cdiv class=\"product-detail-large\"\u003e\n  \u003cdiv class=\"product-hero-large\"\u003e\n    \u003cdiv class=\"hero-badge-large\"\u003eAAV2\/1 Vector\u003c\/div\u003e\n    \u003ch2 class=\"hero-title-large\"\u003eAAV-CMV-saCas9-U6-sgRNA(Scramble)\u003c\/h2\u003e\n    \u003cp class=\"hero-subtitle-large\"\u003eCMV + U6 (dual) Promoter • pAAV (AAV2 ITR) • Broad CNS and muscle tropism\u003c\/p\u003e\n    \u003cp class=\"hero-sku-large\"\u003eBHV21500118\u003c\/p\u003e\n  \u003c\/div\u003e\n\n  \u003csection class=\"detail-section-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-blue\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M12 3a9 9 0 1 0 9 9c0-.46-.04-.92-.1-1.36a5.389 5.389 0 0 1-4.4 2.26 5.403 5.403 0 0 1-3.14-9.8c-.44-.06-.9-.1-1.36-.1z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eResearch Background\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cp\u003eFluorescent reporter and control vectors are foundational tools for validating delivery, benchmarking expression levels, and serving as inert controls in experimental designs. \u003cstrong\u003eAAV2\/1 has broad CNS and muscle tropism\u003c\/strong\u003e.\u003c\/p\u003e\n      \u003cp\u003eThis vector uses a dual-promoter design: CMV drives protein-coding transgene expression while U6 drives shRNA expression, enabling simultaneous gene delivery and knockdown. The plasmid backbone is \u003cstrong\u003epAAV (AAV2 ITR)\u003c\/strong\u003e.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\n  \u003csection class=\"detail-section-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-purple\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M13 10V3L4 14h7v7l9-11h-7z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eWhat This AAV Enables\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cdiv class=\"feature-grid-large\"\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eTransgene Function\u003c\/h4\u003e\n          \u003cp\u003esaCas9-U6-sgRNA is the encoded payload for this construct. The sensor\/actuator encoded is \u003cstrong\u003esaCas9\u003c\/strong\u003e.\u003c\/p\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eExpression Pattern\u003c\/h4\u003e\n          \u003cp\u003eExpression is \u003cstrong\u003econstitutive\u003c\/strong\u003e—the transgene is continuously driven by the promoter without requiring an external trigger. The promoter is designed for broad, cell-type-agnostic expression across diverse tissue types.\u003c\/p\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eCapsid Tropism\u003c\/h4\u003e\n          \u003cp\u003eAAV2\/1 has broad CNS and muscle tropism and is widely used for both in vivo and ex vivo applications.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\n  \u003cdiv class=\"two-column-large\"\u003e\n    \u003csection class=\"detail-section-large compact\"\u003e\n      \u003cdiv class=\"section-header-large\"\u003e\n        \u003cdiv class=\"section-icon-large bg-green\"\u003e\n          \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n            \u003cpath d=\"M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n        \u003c\/div\u003e\n        \u003ch3\u003eCommon Applications\u003c\/h3\u003e\n      \u003c\/div\u003e\n      \u003cul class=\"check-list-large\"\u003e\n\u003cli\u003eIn vivo gene delivery\u003c\/li\u003e\n\u003cli\u003eCell labeling\u003c\/li\u003e\n\u003cli\u003ePromoter testing\u003c\/li\u003e\n\u003cli\u003eTransduction benchmarking\u003c\/li\u003e\n\u003c\/ul\u003e\n    \u003c\/section\u003e\n\n    \u003csection class=\"detail-section-large compact\"\u003e\n      \u003cdiv class=\"section-header-large\"\u003e\n        \u003cdiv class=\"section-icon-large bg-orange\"\u003e\n          \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n            \u003cpath d=\"M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n        \u003c\/div\u003e\n        \u003ch3\u003eExperimental Considerations\u003c\/h3\u003e\n      \u003c\/div\u003e\n      \u003cul class=\"bullet-list-large\"\u003e\n\u003cli\u003eAllow sufficient expression time for AAV2\/1 in your target tissue (often 2–4 weeks in vivo).\u003c\/li\u003e\n\u003cli\u003eVerify targeting and expression level in a pilot cohort before committing to large study groups.\u003c\/li\u003e\n\u003cli\u003eUse appropriate controls: saCas9-U6-sgRNA-negative or null-vector matched for serotype and dose.\u003c\/li\u003e\n\u003cli\u003eConfirm expression distribution with immunostaining, in situ hybridization, or imaging as appropriate.\u003c\/li\u003e\n\u003c\/ul\u003e\n    \u003c\/section\u003e\n  \u003c\/div\u003e\n\n  \u003csection class=\"detail-section-large highlight-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-teal\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eControls and Best Practices\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cp\u003eRecommended controls include: (1) a null or fluorophore-only matched vector to separate delivery effects from payload effects; (2) tissue-matched positive controls to confirm transduction efficiency at your injection coordinates and timepoint; (3) dose-response characterization if the phenotype is sensitive to expression level; and (4) replication across biological cohorts or preparations to confirm robustness.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\u003c\/div\u003e\n\u003cstyle\u003e\n  .product-detail-large {\n    font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;\n    color: #1e293b;\n    max-width: 1200px;\n    margin: 0 auto;\n    padding: 2rem;\n    font-size: 1.5rem;\n  }\n  .product-hero-large {\n    text-align: center;\n    padding: 3rem 2rem;\n    background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);\n    border-radius: 16px;\n    margin-bottom: 3rem;\n    border: 2px solid #e2e8f0;\n  }\n  .hero-badge-large {\n    display: inline-block;\n    background: #3b82f6;\n    color: white;\n    padding: 0.5rem 1.5rem;\n    border-radius: 30px;\n    font-size: 1.25rem;\n    font-weight: 700;\n    margin-bottom: 1rem;\n  }\n  .hero-title-large {\n    font-size: 3rem;\n    font-weight: 800;\n    color: #0f172a;\n    margin: 0 0 1rem 0;\n  }\n  .hero-subtitle-large {\n    font-size: 1.75rem;\n    color: #64748b;\n    margin: 0;\n    font-weight: 500;\n  }\n  .detail-section-large {\n    background: white;\n    border-radius: 16px;\n    padding: 2.5rem;\n    margin-bottom: 2.5rem;\n    border: 2px solid #e2e8f0;\n  }\n  .detail-section-large.compact { margin-bottom: 0; height: 100%; }\n  .detail-section-large.highlight-large {\n    background: #f8fafc;\n    border-left: 6px solid #14b8a6;\n  }\n  .section-header-large {\n    display: flex;\n    align-items: center;\n    gap: 1.25rem;\n    margin-bottom: 1.5rem;\n    padding-bottom: 1.25rem;\n    border-bottom: 2px solid #f1f5f9;\n  }\n  .section-icon-large {\n    width: 4rem;\n    height: 4rem;\n    border-radius: 12px;\n    display: flex;\n    align-items: center;\n    justify-content: center;\n    flex-shrink: 0;\n  }\n  .section-icon-large svg { width: 2.25rem; height: 2.25rem; color: white; }\n  .bg-blue { background: #3b82f6; }\n  .bg-purple { background: #8b5cf6; }\n  .bg-green { background: #10b981; }\n  .bg-orange { background: #f59e0b; }\n  .bg-teal { background: #14b8a6; }\n  .detail-section-large h3 { font-size: 2.25rem; font-weight: 800; color: #0f172a; margin: 0; }\n  .section-body-large p { font-size: 1.5rem; line-height: 1.6; color: #334155; margin: 0 0 1.5rem 0; }\n  .section-body-large p:last-child { margin-bottom: 0; }\n  .section-body-large strong { color: #0f172a; font-weight: 700; }\n  .feature-grid-large { display: flex; flex-direction: column; gap: 2rem; }\n  .feature-item-large h4 { font-size: 1.75rem; font-weight: 700; color: #0f172a; margin: 0 0 0.75rem 0; }\n  .feature-item-large p { font-size: 1.5rem; line-height: 1.6; color: #475569; margin: 0; }\n  .two-column-large { display: grid; grid-template-columns: 1fr 1fr; gap: 2.5rem; margin-bottom: 2.5rem; }\n  .check-list-large { list-style: none; padding: 0; margin: 0; }\n  .check-list-large li {\n    padding: 1rem 0 1rem 3rem;\n    position: relative;\n    font-size: 1.5rem;\n    color: #334155;\n    border-bottom: 2px solid #f8fafc;\n    line-height: 1.5;\n  }\n  .check-list-large li:last-child { border-bottom: none; }\n  .check-list-large li::before {\n    content: \"✓\";\n    position: absolute;\n    left: 0;\n    color: #10b981;\n    font-weight: 800;\n    font-size: 2rem;\n    top: 0.875rem;\n  }\n  .bullet-list-large { list-style: none; padding: 0; margin: 0; }\n  .bullet-list-large li {\n    padding: 1rem 0 1rem 2.5rem;\n    position: relative;\n    font-size: 1.5rem;\n    line-height: 1.6;\n    color: #334155;\n    border-bottom: 2px solid #f8fafc;\n  }\n  .bullet-list-large li:last-child { border-bottom: none; }\n  .bullet-list-large li::before {\n    content: \"•\";\n    position: absolute;\n    left: 0;\n    color: #f59e0b;\n    font-weight: 900;\n    font-size: 2.5rem;\n    line-height: 1;\n    top: 0.5rem;\n  }\n  @media (max-width: 1024px) { .two-column-large { grid-template-columns: 1fr; } }\n  @media (max-width: 768px) {\n    .product-detail-large { padding: 1.5rem; font-size: 1.25rem; }\n    .hero-title-large { font-size: 2.25rem; }\n    .hero-subtitle-large { font-size: 1.5rem; }\n    .detail-section-large h3 { font-size: 1.875rem; }\n    .section-body-large p, .feature-item-large p,\n    .check-list-large li, .bullet-list-large li { font-size: 1.25rem; }\n    .detail-section-large { padding: 1.75rem; }\n  }\n\n  .hero-sku-large { font-size: 1.1rem; color: #94a3b8; margin: 0.75rem 0 0 0; letter-spacing: 0.05em; font-weight: 500; }\n\u003c\/style\u003e","brand":"Biohippo Inc","offers":[{"title":"AAV2\/1 \/ 1.00E+13 VG\/mL \/ 30 uL (Std Pack)","offer_id":53020173074797,"sku":"SL101136-30UL","price":488.0,"currency_code":"USD","in_stock":true},{"title":"AAV2\/1 \/ 1.00E+13 VG\/mL \/ 10 uL (Trial Pack)","offer_id":53020173107565,"sku":"SL101136-10UL","price":168.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/BHV21500118_aav-cmv-sacas9-u6-sgrna-scramble-aav-serotype-1_SL101136.png?v=1770796211"},{"product_id":"aav-cmv-sacas9-u6-sgrna-scramble-aav-serotype-9-bhv21500119","title":"AAV-CMV-saCas9-U6-sgRNA(Scramble) (AAV Serotype 9)","description":"\u003cdiv class=\"product-detail-large\"\u003e\n  \u003cdiv class=\"product-hero-large\"\u003e\n    \u003cdiv class=\"hero-badge-large\"\u003eAAV2\/9 Vector\u003c\/div\u003e\n    \u003ch2 class=\"hero-title-large\"\u003eAAV-CMV-saCas9-U6-sgRNA(Scramble)\u003c\/h2\u003e\n    \u003cp class=\"hero-subtitle-large\"\u003eCMV + U6 (dual) Promoter • pAAV (AAV2 ITR) • Blood-brain barrier crossing with widespread CNS transduction\u003c\/p\u003e\n    \u003cp class=\"hero-sku-large\"\u003eBHV21500119\u003c\/p\u003e\n  \u003c\/div\u003e\n\n  \u003csection class=\"detail-section-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-blue\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M12 3a9 9 0 1 0 9 9c0-.46-.04-.92-.1-1.36a5.389 5.389 0 0 1-4.4 2.26 5.403 5.403 0 0 1-3.14-9.8c-.44-.06-.9-.1-1.36-.1z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eResearch Background\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cp\u003eFluorescent reporter and control vectors are foundational tools for validating delivery, benchmarking expression levels, and serving as inert controls in experimental designs. \u003cstrong\u003eAAV2\/9 has blood-brain barrier crossing with widespread CNS transduction\u003c\/strong\u003e.\u003c\/p\u003e\n      \u003cp\u003eThis vector uses a dual-promoter design: CMV drives protein-coding transgene expression while U6 drives shRNA expression, enabling simultaneous gene delivery and knockdown. The plasmid backbone is \u003cstrong\u003epAAV (AAV2 ITR)\u003c\/strong\u003e.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\n  \u003csection class=\"detail-section-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-purple\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M13 10V3L4 14h7v7l9-11h-7z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eWhat This AAV Enables\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cdiv class=\"feature-grid-large\"\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eTransgene Function\u003c\/h4\u003e\n          \u003cp\u003esaCas9-U6-sgRNA is the encoded payload for this construct. The sensor\/actuator encoded is \u003cstrong\u003esaCas9\u003c\/strong\u003e.\u003c\/p\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eExpression Pattern\u003c\/h4\u003e\n          \u003cp\u003eExpression is \u003cstrong\u003econstitutive\u003c\/strong\u003e—the transgene is continuously driven by the promoter without requiring an external trigger. The promoter is designed for broad, cell-type-agnostic expression across diverse tissue types.\u003c\/p\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eCapsid Tropism\u003c\/h4\u003e\n          \u003cp\u003eAAV2\/9 crosses the blood-brain barrier efficiently and offers widespread CNS transduction, widely used in neuroscience and gene therapy.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\n  \u003cdiv class=\"two-column-large\"\u003e\n    \u003csection class=\"detail-section-large compact\"\u003e\n      \u003cdiv class=\"section-header-large\"\u003e\n        \u003cdiv class=\"section-icon-large bg-green\"\u003e\n          \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n            \u003cpath d=\"M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n        \u003c\/div\u003e\n        \u003ch3\u003eCommon Applications\u003c\/h3\u003e\n      \u003c\/div\u003e\n      \u003cul class=\"check-list-large\"\u003e\n\u003cli\u003eIn vivo gene delivery\u003c\/li\u003e\n\u003cli\u003eCell labeling\u003c\/li\u003e\n\u003cli\u003ePromoter testing\u003c\/li\u003e\n\u003cli\u003eTransduction benchmarking\u003c\/li\u003e\n\u003c\/ul\u003e\n    \u003c\/section\u003e\n\n    \u003csection class=\"detail-section-large compact\"\u003e\n      \u003cdiv class=\"section-header-large\"\u003e\n        \u003cdiv class=\"section-icon-large bg-orange\"\u003e\n          \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n            \u003cpath d=\"M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n        \u003c\/div\u003e\n        \u003ch3\u003eExperimental Considerations\u003c\/h3\u003e\n      \u003c\/div\u003e\n      \u003cul class=\"bullet-list-large\"\u003e\n\u003cli\u003eAllow sufficient expression time for AAV2\/9 in your target tissue (often 2–4 weeks in vivo).\u003c\/li\u003e\n\u003cli\u003eVerify targeting and expression level in a pilot cohort before committing to large study groups.\u003c\/li\u003e\n\u003cli\u003eUse appropriate controls: saCas9-U6-sgRNA-negative or null-vector matched for serotype and dose.\u003c\/li\u003e\n\u003cli\u003eConfirm expression distribution with immunostaining, in situ hybridization, or imaging as appropriate.\u003c\/li\u003e\n\u003c\/ul\u003e\n    \u003c\/section\u003e\n  \u003c\/div\u003e\n\n  \u003csection class=\"detail-section-large highlight-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-teal\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eControls and Best Practices\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cp\u003eRecommended controls include: (1) a null or fluorophore-only matched vector to separate delivery effects from payload effects; (2) tissue-matched positive controls to confirm transduction efficiency at your injection coordinates and timepoint; (3) dose-response characterization if the phenotype is sensitive to expression level; and (4) replication across biological cohorts or preparations to confirm robustness.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\u003c\/div\u003e\n\u003cstyle\u003e\n  .product-detail-large {\n    font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;\n    color: #1e293b;\n    max-width: 1200px;\n    margin: 0 auto;\n    padding: 2rem;\n    font-size: 1.5rem;\n  }\n  .product-hero-large {\n    text-align: center;\n    padding: 3rem 2rem;\n    background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);\n    border-radius: 16px;\n    margin-bottom: 3rem;\n    border: 2px solid #e2e8f0;\n  }\n  .hero-badge-large {\n    display: inline-block;\n    background: #3b82f6;\n    color: white;\n    padding: 0.5rem 1.5rem;\n    border-radius: 30px;\n    font-size: 1.25rem;\n    font-weight: 700;\n    margin-bottom: 1rem;\n  }\n  .hero-title-large {\n    font-size: 3rem;\n    font-weight: 800;\n    color: #0f172a;\n    margin: 0 0 1rem 0;\n  }\n  .hero-subtitle-large {\n    font-size: 1.75rem;\n    color: #64748b;\n    margin: 0;\n    font-weight: 500;\n  }\n  .detail-section-large {\n    background: white;\n    border-radius: 16px;\n    padding: 2.5rem;\n    margin-bottom: 2.5rem;\n    border: 2px solid #e2e8f0;\n  }\n  .detail-section-large.compact { margin-bottom: 0; height: 100%; }\n  .detail-section-large.highlight-large {\n    background: #f8fafc;\n    border-left: 6px solid #14b8a6;\n  }\n  .section-header-large {\n    display: flex;\n    align-items: center;\n    gap: 1.25rem;\n    margin-bottom: 1.5rem;\n    padding-bottom: 1.25rem;\n    border-bottom: 2px solid #f1f5f9;\n  }\n  .section-icon-large {\n    width: 4rem;\n    height: 4rem;\n    border-radius: 12px;\n    display: flex;\n    align-items: center;\n    justify-content: center;\n    flex-shrink: 0;\n  }\n  .section-icon-large svg { width: 2.25rem; height: 2.25rem; color: white; }\n  .bg-blue { background: #3b82f6; }\n  .bg-purple { background: #8b5cf6; }\n  .bg-green { background: #10b981; }\n  .bg-orange { background: #f59e0b; }\n  .bg-teal { background: #14b8a6; }\n  .detail-section-large h3 { font-size: 2.25rem; font-weight: 800; color: #0f172a; margin: 0; }\n  .section-body-large p { font-size: 1.5rem; line-height: 1.6; color: #334155; margin: 0 0 1.5rem 0; }\n  .section-body-large p:last-child { margin-bottom: 0; }\n  .section-body-large strong { color: #0f172a; font-weight: 700; }\n  .feature-grid-large { display: flex; flex-direction: column; gap: 2rem; }\n  .feature-item-large h4 { font-size: 1.75rem; font-weight: 700; color: #0f172a; margin: 0 0 0.75rem 0; }\n  .feature-item-large p { font-size: 1.5rem; line-height: 1.6; color: #475569; margin: 0; }\n  .two-column-large { display: grid; grid-template-columns: 1fr 1fr; gap: 2.5rem; margin-bottom: 2.5rem; }\n  .check-list-large { list-style: none; padding: 0; margin: 0; }\n  .check-list-large li {\n    padding: 1rem 0 1rem 3rem;\n    position: relative;\n    font-size: 1.5rem;\n    color: #334155;\n    border-bottom: 2px solid #f8fafc;\n    line-height: 1.5;\n  }\n  .check-list-large li:last-child { border-bottom: none; }\n  .check-list-large li::before {\n    content: \"✓\";\n    position: absolute;\n    left: 0;\n    color: #10b981;\n    font-weight: 800;\n    font-size: 2rem;\n    top: 0.875rem;\n  }\n  .bullet-list-large { list-style: none; padding: 0; margin: 0; }\n  .bullet-list-large li {\n    padding: 1rem 0 1rem 2.5rem;\n    position: relative;\n    font-size: 1.5rem;\n    line-height: 1.6;\n    color: #334155;\n    border-bottom: 2px solid #f8fafc;\n  }\n  .bullet-list-large li:last-child { border-bottom: none; }\n  .bullet-list-large li::before {\n    content: \"•\";\n    position: absolute;\n    left: 0;\n    color: #f59e0b;\n    font-weight: 900;\n    font-size: 2.5rem;\n    line-height: 1;\n    top: 0.5rem;\n  }\n  @media (max-width: 1024px) { .two-column-large { grid-template-columns: 1fr; } }\n  @media (max-width: 768px) {\n    .product-detail-large { padding: 1.5rem; font-size: 1.25rem; }\n    .hero-title-large { font-size: 2.25rem; }\n    .hero-subtitle-large { font-size: 1.5rem; }\n    .detail-section-large h3 { font-size: 1.875rem; }\n    .section-body-large p, .feature-item-large p,\n    .check-list-large li, .bullet-list-large li { font-size: 1.25rem; }\n    .detail-section-large { padding: 1.75rem; }\n  }\n\n  .hero-sku-large { font-size: 1.1rem; color: #94a3b8; margin: 0.75rem 0 0 0; letter-spacing: 0.05em; font-weight: 500; }\n\u003c\/style\u003e","brand":"Biohippo Inc","offers":[{"title":"AAV2\/9 \/ 1.00E+13 VG\/mL \/ 30 uL (Std Pack)","offer_id":53020173140333,"sku":"SL101137-30UL","price":488.0,"currency_code":"USD","in_stock":true},{"title":"AAV2\/9 \/ 1.00E+13 VG\/mL \/ 10 uL (Trial Pack)","offer_id":53020173173101,"sku":"SL101137-10UL","price":168.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/BHV21500119_aav-cmv-sacas9-u6-sgrna-scramble-aav-serotype-9_SL101137.png?v=1770796212"},{"product_id":"aav-cmv-hcas9-aav-serotype-9-bhv21500158","title":"AAV-CMV-hCas9 (AAV Serotype 9)","description":"\u003cdiv class=\"product-detail-large\"\u003e\n  \u003cdiv class=\"product-hero-large\"\u003e\n    \u003cdiv class=\"hero-badge-large\"\u003eAAV2\/9 Vector\u003c\/div\u003e\n    \u003ch2 class=\"hero-title-large\"\u003eAAV-CMV-hCas9\u003c\/h2\u003e\n    \u003cp class=\"hero-subtitle-large\"\u003eCMV Promoter • pAAV (AAV2 ITR) • Blood-brain barrier crossing with widespread CNS transduction\u003c\/p\u003e\n    \u003cp class=\"hero-sku-large\"\u003eBHV21500158\u003c\/p\u003e\n  \u003c\/div\u003e\n\n  \u003csection class=\"detail-section-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-blue\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M12 3a9 9 0 1 0 9 9c0-.46-.04-.92-.1-1.36a5.389 5.389 0 0 1-4.4 2.26 5.403 5.403 0 0 1-3.14-9.8c-.44-.06-.9-.1-1.36-.1z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eResearch Background\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cp\u003eThis vector encodes a specialized payload for targeted gene modulation, including tools such as RNA interference constructs, genome editors, or other functional effectors. \u003cstrong\u003eAAV2\/9 has blood-brain barrier crossing with widespread CNS transduction\u003c\/strong\u003e.\u003c\/p\u003e\n      \u003cp\u003eCMV is a strong constitutive viral promoter that drives high-level expression across most cell types; activity can diminish over time in some in vivo settings. The plasmid backbone is \u003cstrong\u003epAAV (AAV2 ITR)\u003c\/strong\u003e.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\n  \u003csection class=\"detail-section-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-purple\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M13 10V3L4 14h7v7l9-11h-7z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eWhat This AAV Enables\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cdiv class=\"feature-grid-large\"\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eTransgene Function\u003c\/h4\u003e\n          \u003cp\u003ehCas9 is the encoded payload for this construct. The sensor\/actuator encoded is \u003cstrong\u003eCas9\u003c\/strong\u003e.\u003c\/p\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eExpression Pattern\u003c\/h4\u003e\n          \u003cp\u003eExpression is \u003cstrong\u003econstitutive\u003c\/strong\u003e—the transgene is continuously driven by the promoter without requiring an external trigger. The promoter is designed for broad, cell-type-agnostic expression across diverse tissue types.\u003c\/p\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eCapsid Tropism\u003c\/h4\u003e\n          \u003cp\u003eAAV2\/9 crosses the blood-brain barrier efficiently and offers widespread CNS transduction, widely used in neuroscience and gene therapy.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\n  \u003cdiv class=\"two-column-large\"\u003e\n    \u003csection class=\"detail-section-large compact\"\u003e\n      \u003cdiv class=\"section-header-large\"\u003e\n        \u003cdiv class=\"section-icon-large bg-green\"\u003e\n          \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n            \u003cpath d=\"M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n        \u003c\/div\u003e\n        \u003ch3\u003eCommon Applications\u003c\/h3\u003e\n      \u003c\/div\u003e\n      \u003cul class=\"check-list-large\"\u003e\n\u003cli\u003eIn vivo gene delivery\u003c\/li\u003e\n\u003cli\u003eCRISPR genome editing\u003c\/li\u003e\n\u003c\/ul\u003e\n    \u003c\/section\u003e\n\n    \u003csection class=\"detail-section-large compact\"\u003e\n      \u003cdiv class=\"section-header-large\"\u003e\n        \u003cdiv class=\"section-icon-large bg-orange\"\u003e\n          \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n            \u003cpath d=\"M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n        \u003c\/div\u003e\n        \u003ch3\u003eExperimental Considerations\u003c\/h3\u003e\n      \u003c\/div\u003e\n      \u003cul class=\"bullet-list-large\"\u003e\n\u003cli\u003eAllow sufficient expression time for AAV2\/9 in your target tissue (often 2–4 weeks in vivo).\u003c\/li\u003e\n\u003cli\u003eVerify targeting and expression level in a pilot cohort before committing to large study groups.\u003c\/li\u003e\n\u003cli\u003eUse appropriate controls: hCas9-negative or null-vector matched for serotype and dose.\u003c\/li\u003e\n\u003cli\u003eConfirm expression distribution with immunostaining, in situ hybridization, or imaging as appropriate.\u003c\/li\u003e\n\u003c\/ul\u003e\n    \u003c\/section\u003e\n  \u003c\/div\u003e\n\n  \u003csection class=\"detail-section-large highlight-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-teal\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eControls and Best Practices\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cp\u003eRecommended controls include: (1) a null or fluorophore-only matched vector to separate delivery effects from payload effects; (2) tissue-matched positive controls to confirm transduction efficiency at your injection coordinates and timepoint; (3) dose-response characterization if the phenotype is sensitive to expression level; and (4) replication across biological cohorts or preparations to confirm robustness.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\u003c\/div\u003e\n\u003cstyle\u003e\n  .product-detail-large {\n    font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;\n    color: #1e293b;\n    max-width: 1200px;\n    margin: 0 auto;\n    padding: 2rem;\n    font-size: 1.5rem;\n  }\n  .product-hero-large {\n    text-align: center;\n    padding: 3rem 2rem;\n    background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);\n    border-radius: 16px;\n    margin-bottom: 3rem;\n    border: 2px solid #e2e8f0;\n  }\n  .hero-badge-large {\n    display: inline-block;\n    background: #3b82f6;\n    color: white;\n    padding: 0.5rem 1.5rem;\n    border-radius: 30px;\n    font-size: 1.25rem;\n    font-weight: 700;\n    margin-bottom: 1rem;\n  }\n  .hero-title-large {\n    font-size: 3rem;\n    font-weight: 800;\n    color: #0f172a;\n    margin: 0 0 1rem 0;\n  }\n  .hero-subtitle-large {\n    font-size: 1.75rem;\n    color: #64748b;\n    margin: 0;\n    font-weight: 500;\n  }\n  .detail-section-large {\n    background: white;\n    border-radius: 16px;\n    padding: 2.5rem;\n    margin-bottom: 2.5rem;\n    border: 2px solid #e2e8f0;\n  }\n  .detail-section-large.compact { margin-bottom: 0; height: 100%; }\n  .detail-section-large.highlight-large {\n    background: #f8fafc;\n    border-left: 6px solid #14b8a6;\n  }\n  .section-header-large {\n    display: flex;\n    align-items: center;\n    gap: 1.25rem;\n    margin-bottom: 1.5rem;\n    padding-bottom: 1.25rem;\n    border-bottom: 2px solid #f1f5f9;\n  }\n  .section-icon-large {\n    width: 4rem;\n    height: 4rem;\n    border-radius: 12px;\n    display: flex;\n    align-items: center;\n    justify-content: center;\n    flex-shrink: 0;\n  }\n  .section-icon-large svg { width: 2.25rem; height: 2.25rem; color: white; }\n  .bg-blue { background: #3b82f6; }\n  .bg-purple { background: #8b5cf6; }\n  .bg-green { background: #10b981; }\n  .bg-orange { background: #f59e0b; }\n  .bg-teal { background: #14b8a6; }\n  .detail-section-large h3 { font-size: 2.25rem; font-weight: 800; color: #0f172a; margin: 0; }\n  .section-body-large p { font-size: 1.5rem; line-height: 1.6; color: #334155; margin: 0 0 1.5rem 0; }\n  .section-body-large p:last-child { margin-bottom: 0; }\n  .section-body-large strong { color: #0f172a; font-weight: 700; }\n  .feature-grid-large { display: flex; flex-direction: column; gap: 2rem; }\n  .feature-item-large h4 { font-size: 1.75rem; font-weight: 700; color: #0f172a; margin: 0 0 0.75rem 0; }\n  .feature-item-large p { font-size: 1.5rem; line-height: 1.6; color: #475569; margin: 0; }\n  .two-column-large { display: grid; grid-template-columns: 1fr 1fr; gap: 2.5rem; margin-bottom: 2.5rem; }\n  .check-list-large { list-style: none; padding: 0; margin: 0; }\n  .check-list-large li {\n    padding: 1rem 0 1rem 3rem;\n    position: relative;\n    font-size: 1.5rem;\n    color: #334155;\n    border-bottom: 2px solid #f8fafc;\n    line-height: 1.5;\n  }\n  .check-list-large li:last-child { border-bottom: none; }\n  .check-list-large li::before {\n    content: \"✓\";\n    position: absolute;\n    left: 0;\n    color: #10b981;\n    font-weight: 800;\n    font-size: 2rem;\n    top: 0.875rem;\n  }\n  .bullet-list-large { list-style: none; padding: 0; margin: 0; }\n  .bullet-list-large li {\n    padding: 1rem 0 1rem 2.5rem;\n    position: relative;\n    font-size: 1.5rem;\n    line-height: 1.6;\n    color: #334155;\n    border-bottom: 2px solid #f8fafc;\n  }\n  .bullet-list-large li:last-child { border-bottom: none; }\n  .bullet-list-large li::before {\n    content: \"•\";\n    position: absolute;\n    left: 0;\n    color: #f59e0b;\n    font-weight: 900;\n    font-size: 2.5rem;\n    line-height: 1;\n    top: 0.5rem;\n  }\n  @media (max-width: 1024px) { .two-column-large { grid-template-columns: 1fr; } }\n  @media (max-width: 768px) {\n    .product-detail-large { padding: 1.5rem; font-size: 1.25rem; }\n    .hero-title-large { font-size: 2.25rem; }\n    .hero-subtitle-large { font-size: 1.5rem; }\n    .detail-section-large h3 { font-size: 1.875rem; }\n    .section-body-large p, .feature-item-large p,\n    .check-list-large li, .bullet-list-large li { font-size: 1.25rem; }\n    .detail-section-large { padding: 1.75rem; }\n  }\n\n  .hero-sku-large { font-size: 1.1rem; color: #94a3b8; margin: 0.75rem 0 0 0; letter-spacing: 0.05em; font-weight: 500; }\n\u003c\/style\u003e","brand":"Biohippo Inc","offers":[{"title":"AAV2\/9 \/ 1.00E+13 VG\/mL \/ 30 uL (Std Pack)","offer_id":53020175892845,"sku":"SL101404-30UL","price":488.0,"currency_code":"USD","in_stock":true},{"title":"AAV2\/9 \/ 1.00E+13 VG\/mL \/ 10 uL (Trial Pack)","offer_id":53020175925613,"sku":"SL101404-10UL","price":168.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/BHV21500158_aav-cmv-hcas9-aav-serotype-9_SL101404.png?v=1770796229"},{"product_id":"aav-cmv-sacas9-u6-sgrna-scramble-aav-serotype-8-bhv21500208","title":"AAV-CMV-saCas9-U6-sgRNA(Scramble) (AAV Serotype 8)","description":"\u003cdiv class=\"product-detail-large\"\u003e\n  \u003cdiv class=\"product-hero-large\"\u003e\n    \u003cdiv class=\"hero-badge-large\"\u003eAAV2\/8 Vector\u003c\/div\u003e\n    \u003ch2 class=\"hero-title-large\"\u003eAAV-CMV-saCas9-U6-sgRNA(Scramble)\u003c\/h2\u003e\n    \u003cp class=\"hero-subtitle-large\"\u003eCMV + U6 (dual) Promoter • pAAV (AAV2 ITR) • Efficient liver transduction with broader CNS access than AAV2\/2\u003c\/p\u003e\n    \u003cp class=\"hero-sku-large\"\u003eBHV21500208\u003c\/p\u003e\n  \u003c\/div\u003e\n\n  \u003csection class=\"detail-section-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-blue\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M12 3a9 9 0 1 0 9 9c0-.46-.04-.92-.1-1.36a5.389 5.389 0 0 1-4.4 2.26 5.403 5.403 0 0 1-3.14-9.8c-.44-.06-.9-.1-1.36-.1z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eResearch Background\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cp\u003eFluorescent reporter and control vectors are foundational tools for validating delivery, benchmarking expression levels, and serving as inert controls in experimental designs. \u003cstrong\u003eAAV2\/8 has efficient liver transduction with broader CNS access than AAV2\/2\u003c\/strong\u003e.\u003c\/p\u003e\n      \u003cp\u003eThis vector uses a dual-promoter design: CMV drives protein-coding transgene expression while U6 drives shRNA expression, enabling simultaneous gene delivery and knockdown. The plasmid backbone is \u003cstrong\u003epAAV (AAV2 ITR)\u003c\/strong\u003e.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\n  \u003csection class=\"detail-section-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-purple\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M13 10V3L4 14h7v7l9-11h-7z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eWhat This AAV Enables\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cdiv class=\"feature-grid-large\"\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eTransgene Function\u003c\/h4\u003e\n          \u003cp\u003esaCas9-U6-sgRNA is the encoded payload for this construct. The sensor\/actuator encoded is \u003cstrong\u003esaCas9\u003c\/strong\u003e.\u003c\/p\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eExpression Pattern\u003c\/h4\u003e\n          \u003cp\u003eExpression is \u003cstrong\u003econstitutive\u003c\/strong\u003e—the transgene is continuously driven by the promoter without requiring an external trigger. The promoter is designed for broad, cell-type-agnostic expression across diverse tissue types.\u003c\/p\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eCapsid Tropism\u003c\/h4\u003e\n          \u003cp\u003eAAV2\/8 provides efficient liver transduction and broader CNS access compared to AAV2\/2, making it popular in gene therapy research.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\n  \u003cdiv class=\"two-column-large\"\u003e\n    \u003csection class=\"detail-section-large compact\"\u003e\n      \u003cdiv class=\"section-header-large\"\u003e\n        \u003cdiv class=\"section-icon-large bg-green\"\u003e\n          \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n            \u003cpath d=\"M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n        \u003c\/div\u003e\n        \u003ch3\u003eCommon Applications\u003c\/h3\u003e\n      \u003c\/div\u003e\n      \u003cul class=\"check-list-large\"\u003e\n\u003cli\u003eIn vivo gene delivery\u003c\/li\u003e\n\u003cli\u003eCell labeling\u003c\/li\u003e\n\u003cli\u003ePromoter testing\u003c\/li\u003e\n\u003cli\u003eTransduction benchmarking\u003c\/li\u003e\n\u003c\/ul\u003e\n    \u003c\/section\u003e\n\n    \u003csection class=\"detail-section-large compact\"\u003e\n      \u003cdiv class=\"section-header-large\"\u003e\n        \u003cdiv class=\"section-icon-large bg-orange\"\u003e\n          \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n            \u003cpath d=\"M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n        \u003c\/div\u003e\n        \u003ch3\u003eExperimental Considerations\u003c\/h3\u003e\n      \u003c\/div\u003e\n      \u003cul class=\"bullet-list-large\"\u003e\n\u003cli\u003eAllow sufficient expression time for AAV2\/8 in your target tissue (often 2–4 weeks in vivo).\u003c\/li\u003e\n\u003cli\u003eVerify targeting and expression level in a pilot cohort before committing to large study groups.\u003c\/li\u003e\n\u003cli\u003eUse appropriate controls: saCas9-U6-sgRNA-negative or null-vector matched for serotype and dose.\u003c\/li\u003e\n\u003cli\u003eConfirm expression distribution with immunostaining, in situ hybridization, or imaging as appropriate.\u003c\/li\u003e\n\u003c\/ul\u003e\n    \u003c\/section\u003e\n  \u003c\/div\u003e\n\n  \u003csection class=\"detail-section-large highlight-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-teal\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eControls and Best Practices\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cp\u003eRecommended controls include: (1) a null or fluorophore-only matched vector to separate delivery effects from payload effects; (2) tissue-matched positive controls to confirm transduction efficiency at your injection coordinates and timepoint; (3) dose-response characterization if the phenotype is sensitive to expression level; and (4) replication across biological cohorts or preparations to confirm robustness.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\u003c\/div\u003e\n\u003cstyle\u003e\n  .product-detail-large {\n    font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;\n    color: #1e293b;\n    max-width: 1200px;\n    margin: 0 auto;\n    padding: 2rem;\n    font-size: 1.5rem;\n  }\n  .product-hero-large {\n    text-align: center;\n    padding: 3rem 2rem;\n    background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);\n    border-radius: 16px;\n    margin-bottom: 3rem;\n    border: 2px solid #e2e8f0;\n  }\n  .hero-badge-large {\n    display: inline-block;\n    background: #3b82f6;\n    color: white;\n    padding: 0.5rem 1.5rem;\n    border-radius: 30px;\n    font-size: 1.25rem;\n    font-weight: 700;\n    margin-bottom: 1rem;\n  }\n  .hero-title-large {\n    font-size: 3rem;\n    font-weight: 800;\n    color: #0f172a;\n    margin: 0 0 1rem 0;\n  }\n  .hero-subtitle-large {\n    font-size: 1.75rem;\n    color: #64748b;\n    margin: 0;\n    font-weight: 500;\n  }\n  .detail-section-large {\n    background: white;\n    border-radius: 16px;\n    padding: 2.5rem;\n    margin-bottom: 2.5rem;\n    border: 2px solid #e2e8f0;\n  }\n  .detail-section-large.compact { margin-bottom: 0; height: 100%; }\n  .detail-section-large.highlight-large {\n    background: #f8fafc;\n    border-left: 6px solid #14b8a6;\n  }\n  .section-header-large {\n    display: flex;\n    align-items: center;\n    gap: 1.25rem;\n    margin-bottom: 1.5rem;\n    padding-bottom: 1.25rem;\n    border-bottom: 2px solid #f1f5f9;\n  }\n  .section-icon-large {\n    width: 4rem;\n    height: 4rem;\n    border-radius: 12px;\n    display: flex;\n    align-items: center;\n    justify-content: center;\n    flex-shrink: 0;\n  }\n  .section-icon-large svg { width: 2.25rem; height: 2.25rem; color: white; }\n  .bg-blue { background: #3b82f6; }\n  .bg-purple { background: #8b5cf6; }\n  .bg-green { background: #10b981; }\n  .bg-orange { background: #f59e0b; }\n  .bg-teal { background: #14b8a6; }\n  .detail-section-large h3 { font-size: 2.25rem; font-weight: 800; color: #0f172a; margin: 0; }\n  .section-body-large p { font-size: 1.5rem; line-height: 1.6; color: #334155; margin: 0 0 1.5rem 0; }\n  .section-body-large p:last-child { margin-bottom: 0; }\n  .section-body-large strong { color: #0f172a; font-weight: 700; }\n  .feature-grid-large { display: flex; flex-direction: column; gap: 2rem; }\n  .feature-item-large h4 { font-size: 1.75rem; font-weight: 700; color: #0f172a; margin: 0 0 0.75rem 0; }\n  .feature-item-large p { font-size: 1.5rem; line-height: 1.6; color: #475569; margin: 0; }\n  .two-column-large { display: grid; grid-template-columns: 1fr 1fr; gap: 2.5rem; margin-bottom: 2.5rem; }\n  .check-list-large { list-style: none; padding: 0; margin: 0; }\n  .check-list-large li {\n    padding: 1rem 0 1rem 3rem;\n    position: relative;\n    font-size: 1.5rem;\n    color: #334155;\n    border-bottom: 2px solid #f8fafc;\n    line-height: 1.5;\n  }\n  .check-list-large li:last-child { border-bottom: none; }\n  .check-list-large li::before {\n    content: \"✓\";\n    position: absolute;\n    left: 0;\n    color: #10b981;\n    font-weight: 800;\n    font-size: 2rem;\n    top: 0.875rem;\n  }\n  .bullet-list-large { list-style: none; padding: 0; margin: 0; }\n  .bullet-list-large li {\n    padding: 1rem 0 1rem 2.5rem;\n    position: relative;\n    font-size: 1.5rem;\n    line-height: 1.6;\n    color: #334155;\n    border-bottom: 2px solid #f8fafc;\n  }\n  .bullet-list-large li:last-child { border-bottom: none; }\n  .bullet-list-large li::before {\n    content: \"•\";\n    position: absolute;\n    left: 0;\n    color: #f59e0b;\n    font-weight: 900;\n    font-size: 2.5rem;\n    line-height: 1;\n    top: 0.5rem;\n  }\n  @media (max-width: 1024px) { .two-column-large { grid-template-columns: 1fr; } }\n  @media (max-width: 768px) {\n    .product-detail-large { padding: 1.5rem; font-size: 1.25rem; }\n    .hero-title-large { font-size: 2.25rem; }\n    .hero-subtitle-large { font-size: 1.5rem; }\n    .detail-section-large h3 { font-size: 1.875rem; }\n    .section-body-large p, .feature-item-large p,\n    .check-list-large li, .bullet-list-large li { font-size: 1.25rem; }\n    .detail-section-large { padding: 1.75rem; }\n  }\n\n  .hero-sku-large { font-size: 1.1rem; color: #94a3b8; margin: 0.75rem 0 0 0; letter-spacing: 0.05em; font-weight: 500; }\n\u003c\/style\u003e","brand":"Biohippo Inc","offers":[{"title":"AAV2\/8 \/ 1.00E+13 VG\/mL \/ 30 uL (Std Pack)","offer_id":53020179202413,"sku":"SL101465-30UL","price":488.0,"currency_code":"USD","in_stock":true},{"title":"AAV2\/8 \/ 1.00E+13 VG\/mL \/ 10 uL (Trial Pack)","offer_id":53020179235181,"sku":"SL101465-10UL","price":168.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/BHV21500208_aav-cmv-sacas9-u6-sgrna-scramble-aav-serotype-8_SL101465.png?v=1770796247"},{"product_id":"aav-syn-sacas9-serotype-9-bhv21500451","title":"AAV-Syn-SaCas9 (Serotype 9)","description":"\u003cdiv class=\"product-detail-large\"\u003e\n  \u003cdiv class=\"product-hero-large\"\u003e\n    \u003cdiv class=\"hero-badge-large\"\u003eAAV2\/9 Vector\u003c\/div\u003e\n    \u003ch2 class=\"hero-title-large\"\u003eAAV-Syn-SaCas9\u003c\/h2\u003e\n    \u003cp class=\"hero-subtitle-large\"\u003eSynapsin Promoter • pAAV (AAV2 ITR) • Blood-brain barrier crossing with widespread CNS transduction\u003c\/p\u003e\n    \u003cp class=\"hero-sku-large\"\u003eBHV21500451\u003c\/p\u003e\n  \u003c\/div\u003e\n\n  \u003csection class=\"detail-section-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-blue\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M12 3a9 9 0 1 0 9 9c0-.46-.04-.92-.1-1.36a5.389 5.389 0 0 1-4.4 2.26 5.403 5.403 0 0 1-3.14-9.8c-.44-.06-.9-.1-1.36-.1z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eResearch Background\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cp\u003eThis vector encodes a specialized payload for targeted gene modulation, including tools such as RNA interference constructs, genome editors, or other functional effectors. \u003cstrong\u003eAAV2\/9 has blood-brain barrier crossing with widespread CNS transduction\u003c\/strong\u003e.\u003c\/p\u003e\n      \u003cp\u003eThe Synapsin (hSyn) promoter is a compact neuronal promoter that restricts expression to post-mitotic neurons, making it a standard choice for CNS work. The plasmid backbone is \u003cstrong\u003epAAV (AAV2 ITR)\u003c\/strong\u003e.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\n  \u003csection class=\"detail-section-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-purple\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M13 10V3L4 14h7v7l9-11h-7z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eWhat This AAV Enables\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cdiv class=\"feature-grid-large\"\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eTransgene Function\u003c\/h4\u003e\n          \u003cp\u003eSaCas9 is the encoded payload for this construct. The sensor\/actuator encoded is \u003cstrong\u003esaCas9\u003c\/strong\u003e.\u003c\/p\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eExpression Pattern\u003c\/h4\u003e\n          \u003cp\u003eExpression is \u003cstrong\u003econstitutive\u003c\/strong\u003e—the transgene is continuously driven by the promoter without requiring an external trigger. The promoter is designed for expression targeted to post-mitotic neurons.\u003c\/p\u003e\n        \u003c\/div\u003e\n        \u003cdiv class=\"feature-item-large\"\u003e\n          \u003ch4\u003eCapsid Tropism\u003c\/h4\u003e\n          \u003cp\u003eAAV2\/9 crosses the blood-brain barrier efficiently and offers widespread CNS transduction, widely used in neuroscience and gene therapy.\u003c\/p\u003e\n        \u003c\/div\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\n  \u003cdiv class=\"two-column-large\"\u003e\n    \u003csection class=\"detail-section-large compact\"\u003e\n      \u003cdiv class=\"section-header-large\"\u003e\n        \u003cdiv class=\"section-icon-large bg-green\"\u003e\n          \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n            \u003cpath d=\"M9 5H7a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V7a2 2 0 00-2-2h-2M9 5a2 2 0 002 2h2a2 2 0 002-2M9 5a2 2 0 012-2h2a2 2 0 012 2\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n        \u003c\/div\u003e\n        \u003ch3\u003eCommon Applications\u003c\/h3\u003e\n      \u003c\/div\u003e\n      \u003cul class=\"check-list-large\"\u003e\n\u003cli\u003eIn vivo gene delivery\u003c\/li\u003e\n\u003cli\u003eCRISPR genome editing\u003c\/li\u003e\n\u003c\/ul\u003e\n    \u003c\/section\u003e\n\n    \u003csection class=\"detail-section-large compact\"\u003e\n      \u003cdiv class=\"section-header-large\"\u003e\n        \u003cdiv class=\"section-icon-large bg-orange\"\u003e\n          \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n            \u003cpath d=\"M12 9v2m0 4h.01m-6.938 4h13.856c1.54 0 2.502-1.667 1.732-3L13.732 4c-.77-1.333-2.694-1.333-3.464 0L3.34 16c-.77 1.333.192 3 1.732 3z\"\u003e\u003c\/path\u003e\n          \u003c\/svg\u003e\n        \u003c\/div\u003e\n        \u003ch3\u003eExperimental Considerations\u003c\/h3\u003e\n      \u003c\/div\u003e\n      \u003cul class=\"bullet-list-large\"\u003e\n\u003cli\u003eAllow sufficient expression time for AAV2\/9 in your target tissue (often 2–4 weeks in vivo).\u003c\/li\u003e\n\u003cli\u003eVerify targeting and expression level in a pilot cohort before committing to large study groups.\u003c\/li\u003e\n\u003cli\u003eUse appropriate controls: SaCas9-negative or null-vector matched for serotype and dose.\u003c\/li\u003e\n\u003cli\u003eConfirm expression distribution with immunostaining, in situ hybridization, or imaging as appropriate.\u003c\/li\u003e\n\u003c\/ul\u003e\n    \u003c\/section\u003e\n  \u003c\/div\u003e\n\n  \u003csection class=\"detail-section-large highlight-large\"\u003e\n    \u003cdiv class=\"section-header-large\"\u003e\n      \u003cdiv class=\"section-icon-large bg-teal\"\u003e\n        \u003csvg viewbox=\"0 0 24 24\" fill=\"none\" stroke=\"currentColor\" stroke-width=\"2\"\u003e\n          \u003cpath d=\"M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z\"\u003e\u003c\/path\u003e\n        \u003c\/svg\u003e\n      \u003c\/div\u003e\n      \u003ch3\u003eControls and Best Practices\u003c\/h3\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"section-body-large\"\u003e\n      \u003cp\u003eRecommended controls include: (1) a null or fluorophore-only matched vector to separate delivery effects from payload effects; (2) tissue-matched positive controls to confirm transduction efficiency at your injection coordinates and timepoint; (3) dose-response characterization if the phenotype is sensitive to expression level; and (4) replication across biological cohorts or preparations to confirm robustness.\u003c\/p\u003e\n    \u003c\/div\u003e\n  \u003c\/section\u003e\n\u003c\/div\u003e\n\u003cstyle\u003e\n  .product-detail-large {\n    font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;\n    color: #1e293b;\n    max-width: 1200px;\n    margin: 0 auto;\n    padding: 2rem;\n    font-size: 1.5rem;\n  }\n  .product-hero-large {\n    text-align: center;\n    padding: 3rem 2rem;\n    background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);\n    border-radius: 16px;\n    margin-bottom: 3rem;\n    border: 2px solid #e2e8f0;\n  }\n  .hero-badge-large {\n    display: inline-block;\n    background: #3b82f6;\n    color: white;\n    padding: 0.5rem 1.5rem;\n    border-radius: 30px;\n    font-size: 1.25rem;\n    font-weight: 700;\n    margin-bottom: 1rem;\n  }\n  .hero-title-large {\n    font-size: 3rem;\n    font-weight: 800;\n    color: #0f172a;\n    margin: 0 0 1rem 0;\n  }\n  .hero-subtitle-large {\n    font-size: 1.75rem;\n    color: #64748b;\n    margin: 0;\n    font-weight: 500;\n  }\n  .detail-section-large {\n    background: white;\n    border-radius: 16px;\n    padding: 2.5rem;\n    margin-bottom: 2.5rem;\n    border: 2px solid #e2e8f0;\n  }\n  .detail-section-large.compact { margin-bottom: 0; height: 100%; }\n  .detail-section-large.highlight-large {\n    background: #f8fafc;\n    border-left: 6px solid #14b8a6;\n  }\n  .section-header-large {\n    display: flex;\n    align-items: center;\n    gap: 1.25rem;\n    margin-bottom: 1.5rem;\n    padding-bottom: 1.25rem;\n    border-bottom: 2px solid #f1f5f9;\n  }\n  .section-icon-large {\n    width: 4rem;\n    height: 4rem;\n    border-radius: 12px;\n    display: flex;\n    align-items: center;\n    justify-content: center;\n    flex-shrink: 0;\n  }\n  .section-icon-large svg { width: 2.25rem; height: 2.25rem; color: white; }\n  .bg-blue { background: #3b82f6; }\n  .bg-purple { background: #8b5cf6; }\n  .bg-green { background: #10b981; }\n  .bg-orange { background: #f59e0b; }\n  .bg-teal { background: #14b8a6; }\n  .detail-section-large h3 { font-size: 2.25rem; font-weight: 800; color: #0f172a; margin: 0; }\n  .section-body-large p { font-size: 1.5rem; line-height: 1.6; color: #334155; margin: 0 0 1.5rem 0; }\n  .section-body-large p:last-child { margin-bottom: 0; }\n  .section-body-large strong { color: #0f172a; font-weight: 700; }\n  .feature-grid-large { display: flex; flex-direction: column; gap: 2rem; }\n  .feature-item-large h4 { font-size: 1.75rem; font-weight: 700; color: #0f172a; margin: 0 0 0.75rem 0; }\n  .feature-item-large p { font-size: 1.5rem; line-height: 1.6; color: #475569; margin: 0; }\n  .two-column-large { display: grid; grid-template-columns: 1fr 1fr; gap: 2.5rem; margin-bottom: 2.5rem; }\n  .check-list-large { list-style: none; padding: 0; margin: 0; }\n  .check-list-large li {\n    padding: 1rem 0 1rem 3rem;\n    position: relative;\n    font-size: 1.5rem;\n    color: #334155;\n    border-bottom: 2px solid #f8fafc;\n    line-height: 1.5;\n  }\n  .check-list-large li:last-child { border-bottom: none; }\n  .check-list-large li::before {\n    content: \"✓\";\n    position: absolute;\n    left: 0;\n    color: #10b981;\n    font-weight: 800;\n    font-size: 2rem;\n    top: 0.875rem;\n  }\n  .bullet-list-large { list-style: none; padding: 0; margin: 0; }\n  .bullet-list-large li {\n    padding: 1rem 0 1rem 2.5rem;\n    position: relative;\n    font-size: 1.5rem;\n    line-height: 1.6;\n    color: #334155;\n    border-bottom: 2px solid #f8fafc;\n  }\n  .bullet-list-large li:last-child { border-bottom: none; }\n  .bullet-list-large li::before {\n    content: \"•\";\n    position: absolute;\n    left: 0;\n    color: #f59e0b;\n    font-weight: 900;\n    font-size: 2.5rem;\n    line-height: 1;\n    top: 0.5rem;\n  }\n  @media (max-width: 1024px) { .two-column-large { grid-template-columns: 1fr; } }\n  @media (max-width: 768px) {\n    .product-detail-large { padding: 1.5rem; font-size: 1.25rem; }\n    .hero-title-large { font-size: 2.25rem; }\n    .hero-subtitle-large { font-size: 1.5rem; }\n    .detail-section-large h3 { font-size: 1.875rem; }\n    .section-body-large p, .feature-item-large p,\n    .check-list-large li, .bullet-list-large li { font-size: 1.25rem; }\n    .detail-section-large { padding: 1.75rem; }\n  }\n\n  .hero-sku-large { font-size: 1.1rem; color: #94a3b8; margin: 0.75rem 0 0 0; letter-spacing: 0.05em; font-weight: 500; }\n\u003c\/style\u003e","brand":"Biohippo Inc","offers":[{"title":"AAV2\/9 \/ 1.00E+13 VG\/mL \/ 30 uL (Std Pack)","offer_id":53020197552493,"sku":"SL116408-30UL","price":488.0,"currency_code":"USD","in_stock":true},{"title":"AAV2\/9 \/ 1.00E+13 VG\/mL \/ 10 uL (Trial Pack)","offer_id":53020197585261,"sku":"SL116408-10UL","price":168.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0949\/7424\/7277\/files\/BHV21500451_aav-syn-sacas9-serotype-9_SL116408.png?v=1770796334"},{"product_id":"anti-ustekinumab-polyclonal-antibody-bha21403364","title":"Anti-Ustekinumab Polyclonal Antibody","description":"\u003cp\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003cbr\u003eThis antibody is intended for research detection of \u003cstrong\u003eUstekinumab\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTarget\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eUstekinumab (Rabbit polyclonal to Stelara.)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTarget biology\u003c\/strong\u003e\u003cbr\u003eUstekinumab (Rabbit polyclonal to Stelara.) is a protein of interest in cellular and molecular biology. Measuring its abundance and localization can help characterize pathway state, cell identity, or disease-associated changes.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eExpected localization\u003c\/strong\u003e\u003cbr\u003econtext-dependent (may vary by cell type and experimental conditions).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eResearch context\u003c\/strong\u003e\u003cbr\u003eCommonly used in \u003cstrong\u003eMolecular \u0026amp; Cellular Biology\u003c\/strong\u003e workflows to study expression changes, pathway state, and cellular localization of Ustekinumab.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompatible workflows\u003c\/strong\u003e\u003c\/p\u003e\u003cul\u003e\u003cli\u003eELISA\u003c\/li\u003e\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eExperimental notes\u003c\/strong\u003e\u003c\/p\u003e\u003cul\u003e\u003cli\u003eELISA: performance is sensitive to coating conditions and blocking chemistry; optimize capture density and blocking reagent to reduce non‑specific binding.\u003c\/li\u003e\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eControls \u0026amp; interpretation\u003c\/strong\u003e\u003cbr\u003eRecommended controls include a positive sample reported to express the target (literature‑validated cell line or tissue), a negative\/low‑expression sample when available, and ideally genetic knockdown\/knockout or peptide‑blocking approaches to confirm specificity.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmunogen context\u003c\/strong\u003e\u003cbr\u003eUstekinumab\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIntended use\u003c\/strong\u003e\u003cbr\u003eFor research use only. Not for diagnostic procedures.\u003c\/p\u003e","brand":"Biohippo Inc","offers":[{"title":"50 ug","offer_id":53036859097453,"sku":"AB769014-50UG","price":352.0,"currency_code":"USD","in_stock":true},{"title":"100 ug","offer_id":53037438533997,"sku":"AB769014-100UG","price":678.0,"currency_code":"USD","in_stock":true}]},{"product_id":"anti-cetuximab-polyclonal-antibody-bha21403381","title":"Anti-Cetuximab Polyclonal Antibody","description":"\u003cp\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003cbr\u003eThis antibody is intended for research detection of \u003cstrong\u003eCetuximab\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTarget\u003c\/strong\u003e\u003cbr\u003e\u003cstrong\u003eCetuximab (Rabbit polyclonal to Erbitux.)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eTarget biology\u003c\/strong\u003e\u003cbr\u003eCetuximab (Rabbit polyclonal to Erbitux.) is a protein of interest in cellular and molecular biology. Measuring its abundance and localization can help characterize pathway state, cell identity, or disease-associated changes.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eExpected localization\u003c\/strong\u003e\u003cbr\u003econtext-dependent (may vary by cell type and experimental conditions).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eResearch context\u003c\/strong\u003e\u003cbr\u003eCommonly used in \u003cstrong\u003eMolecular \u0026amp; Cellular Biology\u003c\/strong\u003e workflows to study expression changes, pathway state, and cellular localization of Cetuximab.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompatible workflows\u003c\/strong\u003e\u003c\/p\u003e\u003cul\u003e\u003cli\u003eELISA\u003c\/li\u003e\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eExperimental notes\u003c\/strong\u003e\u003c\/p\u003e\u003cul\u003e\u003cli\u003eELISA: performance is sensitive to coating conditions and blocking chemistry; optimize capture density and blocking reagent to reduce non‑specific binding.\u003c\/li\u003e\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eControls \u0026amp; interpretation\u003c\/strong\u003e\u003cbr\u003eRecommended controls include a positive sample reported to express the target (literature‑validated cell line or tissue), a negative\/low‑expression sample when available, and ideally genetic knockdown\/knockout or peptide‑blocking approaches to confirm specificity.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImmunogen context\u003c\/strong\u003e\u003cbr\u003eCetuximab\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIntended use\u003c\/strong\u003e\u003cbr\u003eFor research use only. Not for diagnostic procedures.\u003c\/p\u003e","brand":"Biohippo Inc","offers":[{"title":"50 ug","offer_id":53036859654509,"sku":"AF004014-50UG","price":352.0,"currency_code":"USD","in_stock":true},{"title":"100 ug","offer_id":53037439222125,"sku":"AF004014-100UG","price":678.0,"currency_code":"USD","in_stock":true}]}],"url":"https:\/\/www.ebiohippo.com\/collections\/drug-development.oembed?page=7","provider":"BioHippo","version":"1.0","type":"link"}